ReCARDO CDE Engine

Draft CDEs Under Domain: Treatment

CDEs you are drafting before submitting for review.

Name	Source	Domain	Status	Updated	Actions
# a1 booster sessions	✓ ACTIVE	Treatment	Draft	07 May 16:15	Detail Edit
# a3 booster sessions	✓ ACTIVE	Treatment	Draft	07 May 16:15	Detail Edit
# intervention sessions	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
# of medicines?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
a steroid inhaler	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
a4a ad-specific drug treatment - language	✓ NACC_csv	Treatment	Draft	07 May 16:15	Detail Edit
accept or seek 2nd open heart surgery	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
activity frequency	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
activity type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
acupuncture frequency (12 months)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
acute concussion evaluation (ace) ? follow-up action plan physician clinician office monitoring date	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
acute concussion evaluation (ace) ? follow-up action plan referral physician type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
add adhd medication perscription indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
additional medications freq phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
adenomas procedure phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
adjunctive treatment drool surgical procedure injection specify text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
adjunctive treatment indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
adjunctive treatment other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
adjunctive treatment type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
adjuvant therapy	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
adult cardiac surgery: specify	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
adverse drug reaction indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
adverse event aed action taken text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
adverse event attribution indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
adverse event relatedness scale	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
adverse event study intervention action taken type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
adverse event study intervention date and time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
adverse events to modify adrd biomarkers - amyloid related imaging abnormalities-edeme (aria-e)	✓ NACC_csv	Treatment	Draft	07 May 16:15	Detail Edit
adverse events to modify adrd biomarkers - amyloid related imaging abnormalities-hemorrhage (aria-h)	✓ NACC_csv	Treatment	Draft	07 May 16:15	Detail Edit
adverse events to modify adrd biomarkers - other	✓ NACC_csv	Treatment	Draft	07 May 16:15	Detail Edit
adverse events to modify adrd biomarkers - other, specify	✓ NACC_csv	Treatment	Draft	07 May 16:15	Detail Edit
adverse reaction drug name	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
adverse reaction drug receive year text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
afo type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
age (in months) at beginning of steroid treatment	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
age at first pacemaker and/or defibrillator implantation	✓ NACC_csv	Treatment	Draft	07 May 16:15	Detail Edit
age at first use of female hormone replacement pills	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
age at last use of female hormone replacement pills	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
age at most recent coronary artery bypass surgery	✓ NACC_csv	Treatment	Draft	07 May 16:15	Detail Edit
age at most recent heart valve replacement or repair procedure	✓ NACC_csv	Treatment	Draft	07 May 16:15	Detail Edit
age began taking bp med	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
age began taking cholest med	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
age had removal both ovaries	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
age had removal one ovary	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
age had removal uterus and 1 ovary	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
age had removal uterus and 2 ovaries	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
age had tubal ligation	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
airway treatment type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
alcohol or drug problems: treated in last 12 months?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
alcohol or drug treatment program	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
allergy medication antibiotic name	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
allergy medication antibiotic reaction type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
allergy medication name	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
allergy medication reaction type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
als, alg, ats, atg	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
amyloid beta antibody other specify	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
analgesia type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
anesthesia ever	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
anesthesia most recent common era month	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
anesthesia most recent common era year	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
anesthesia most recent year	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
anesthesia since last visit	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
anesthesia type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
anesthetic type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
aneurysm intervention surgical result status	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
aneurysm reopen neck remnant increase after treatment indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
aneurysm rerupture after primary treatment indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
aneurysm retreatment after primary treatment date	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
aneurysm retreatment after primary treatment indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
aneurysm retreatment endovascular type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
aneurysm retreatment surgical type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
aneurysm retreatment type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
aneurysm rupture occur surgery procedure grade	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
aneurysm treated count	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
aneurysm treatment endovascular type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
aneurysm treatment surgical type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
angiography for claudication or paf	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
angioplasty for claudication or pad	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
animal drug treatment route type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
animal post-injury surgical procedure type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ankle foot orthosis type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ankle foot orthosis use type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
antacids time phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
anti diabetic agent stroke discharge prescribe other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
anti diabetic agent stroke discharge prescribe type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
anti-depressant or anti-anxiety meds	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
antiarrhythmics for treatment of af	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
antibiotic drip infection phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
antibiotic drip phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
antibiotic long term repeated history indication text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
antibiotic long term repeated history indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
antibiotic long term repeated history name	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
antibiotic long term repeated history use year text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
anticoagulant agent in hospital indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
anticoagulant agent in hospital other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
anticoagulant agent in hospital type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
anticoagulant agent stroke discharge prescribe other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
anticoagulant agent stroke discharge prescribe type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
anticoagulants for treatment of af	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
antihypertensive agent stroke discharge prescribe other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
antihypertensive agent stroke discharge prescribe type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
antiplatelet agent in hospital indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
antiplatelet agent in hospital other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
antiplatelet agent in hospital type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
antiplatelet agent stroke discharge prescribe other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
antiplatelet agent stroke discharge prescribe type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
antithrombotic therapy change reason	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
antithrombotic therapy not prescribed other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
antithrombotic therapy not prescribed reason	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
antithrombotic therapy not prescribed serious side effect text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
antithrombotics indication: other	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
antithrombotics treatment goal	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
antithrombotics treatment goal: other	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
any chemo/rad since baseline for	✓ ACTIVE	Treatment	Draft	07 May 16:15	Detail Edit
any medication allergies?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
are you currently being treated for this (e.g., cpap)?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
are you currently on renal dialysis [phenx]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
are you currently taking any of the following medications? (select all that apply)... aripiprazole (abilify)	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
are you currently taking any of the following medications? (select all that apply)... donepezil (aricept)	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
Are you currently taking any of the following medications? (Select all that apply)... Galantamine (Razadyne)	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
Are you currently taking any of the following medications? (Select all that apply)... Memantine (Namenda)	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
are you currently taking any of the following medications? (select all that apply)... olanzapine (zyprexa)	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
are you currently taking any of the following medications? (select all that apply)... paliperidone (invega)	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
Are you currently taking any of the following medications? (Select all that apply)... Quetiapine (Seroquel)	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
are you currently taking any of the following medications? (select all that apply)... risperidone (risperdal)	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
Are you currently taking any of the following medications? (Select all that apply)... Rivastigmine (Exelon)	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
are you currently taking any of the following medications? (select all that apply)... tacrine (cognex)	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
are you currently taking any of the following types of medications? (select all that apply)... anti-anxiety medication	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
are you currently taking any of the following types of medications? (select all that apply)... anti-depressant medication	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
are you currently using ippb?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
are you currently using steroid eye drops [phenx]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
are you currently using them (within the last month)?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
are you on chronic transfusion therapy at this time?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
are you on iron chelation treatment?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
arrival intubation indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
arterial line indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
arthritis, rheumatism, bone or joint: treated in last 12 months?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
as needed	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
as you know, the xx study will be describing all medications its participants are using, both prescription and over-the-counter. these include pills, liquid medications; skin patches, eye drops, creams, salves, inhalers and injections, as well as cold or allergy medications, vitamins, herbal remedies and other supplements. the letter you received about this appointment included a plastic medications bag for all your current medications and asked you to bring them to the clinic. have you brought this bag with you? are these all the medications that you have taken in the past two weeks?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
aspirin dose--post enrollment in adaptable study [adaptable]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
aspirin how long phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
aspirin usage--post enrollment in adaptable study [adaptable]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
assessment surgery procedure vessel patency aneurysm occlusion method type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
at the time of the event, the device was placed within the patient's tissue [ahrq]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
At this visit, is participant on any of the following medication?	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
at what age was diabetes first treated [phenx]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
atg	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
atopic allergic disorder condition medication name	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
avg number pills prescription phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
azathioprine	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
back brace frequency type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
back brace indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
begin age of osteoporosis medication	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
begin age of osteoporosis medication 2.	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
begin age of osteoporosis medication 3.	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
behavioral therapy management indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
best characterization of medication or other substance event [ahrq]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
best description for incorrect strength or concentration [ahrq]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
best description for the incorrect dose [ahrq]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
biofeedback frequency (12 months)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
biological product of medication [ahrq]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
birth control in last w phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
birth control last used date and time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
birth control method at exit reported --at exit	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
birth control method current former use other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
birth control method current former use type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
birth control name and dosage	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
birth control pills	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
birth control pills past 3mo edds	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
birth control taken currently?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
birth control taken in the past?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
birth control use type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
blood glucose lower threshold value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
blood glucose upper threshold value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
blood immune condition medication currently indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
blood immune condition medication name	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
blood immune condition medication past year indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
blood immune condition medication work well indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
blood product given [type]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
blood transfusion surgery procedure indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
blood vessel rupture surgery procedure evidence indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
booster 1 date	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
booster sequence phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
booster type phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
bortezomib	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
bowel function medication constipating agent type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
bowel function medication indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
brand name - rxnorm rxcui of medication	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
brand name of medication	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
brought medications phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
bypass revascularization surgery type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
caesarean delivery timing type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
campath	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
cancer chemotherapy med phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
cancer chemotherapy received in the past 4w	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
cancer chemotherapy received in the past 4w or will be received in the next 4w	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
cancer diagnosis and/or treatment within the past 12 months	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
cancer pharmacotherapy: adjuvant therapy	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
cancer pharmacotherapy: agent	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
cancer pharmacotherapy: intended duration (days)	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
cancer pharmacotherapy: new course	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
cancer therapy - diet	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
cancer therapy - exercise	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
cancer therapy - herbal	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
cancer therapy - meditation/relaxation	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
cancer therapy - vitamins/minerals	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
cancer treatment phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
cancer treatment/therapy currently	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
cardiac implant device location anatomic site	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
cardiac implant device place indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
cardiac pacemaker last insertion date	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
cardiac rehabilitation treatment plan, medication administered set	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
cardiovascular history cardiac surgery type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
carotid artery operation phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
carotid revascularization procedure other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
carotid revascularization procedure type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
cataract surgery ever phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
catheter-related thrombosis: catheter maintenance	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
catheter-related thrombosis: catheter placement guidance	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
catheter-related thrombosis: catheter type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
catheter-related thrombosis: removal date and time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
cerebral spinal fluid drainage indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
cerebrospinal fluid excess volume hour rate	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
cervical compression surgical site status	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
cervical fusion indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
cervical laminectomy anatomic site	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
cervical laminotomy indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
change medication time status text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
changed medication dose text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
changed medication frequency other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
changed medication frequency status	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
changed medication name text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
changed plan: expanded/added: 2nd health	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
changed plan: got help: 2nd health	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
check if any of the following was performed:	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
chemical mechanical intra-arterial balloon angioplasty indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
chemical mechanical therapy subarachnoid hemorrhage day count	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
chemical therapy intra-arterial adverse clinical exam change type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
chemical therapy intra-arterial indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
chemical therapy intra-arterial procedural adverse event other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
chemical therapy intra-arterial procedural adverse event type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
chemical therapy intra-arterial vasodilator other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
chemical therapy intra-arterial vasodilator type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
chest discomfort relief by ntg	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
chest discomfort relief by other	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
chest discomfort relief spontaneous	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
chest operations ever phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
chiari decompression intradural adjunct fourth ventricle stent indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
chiari decompression verification decompression obex choroid plexus fourth ventricle indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
chiari malformation conservative management indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
child current medication dose phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
child current medication effect phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
child ritalin ever phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
child steroids anti-ca drugs phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
child strabismus treatment phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
child surgery ever phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
child transfusion immune globulin phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
chiropractor frequency (12 months)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
chiropractor seen for healthcare	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
chloroquine phosphate	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
choices for your child’s treatment or health care can include choices about medicine, surgery, or other treatment. in the last 6 months, did your child’s doctor or other health provider tell you there was more than one choice for your child’s treatment or health care?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
choose if treated or untreated	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
chronic sleeping problems: treated in last 12 months?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
circulation support type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
clinical drug component - rxnorm rxcui of medication	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
cmfreqid	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
cmrouteid	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
cmunitsid	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
coenzyme q10 phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
cognitive rest after concussion indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
cognitive therapy indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
cognitive training: any others?	✓ ACTIVE	Treatment	Draft	07 May 16:15	Detail Edit
cognitive training: audiotapes or cds	✓ ACTIVE	Treatment	Draft	07 May 16:15	Detail Edit
cognitive training: brain exercise program or center	✓ ACTIVE	Treatment	Draft	07 May 16:15	Detail Edit
cognitive training: dvd or vhs programs	✓ ACTIVE	Treatment	Draft	07 May 16:15	Detail Edit
cognitive training: in-person lecture series or classes	✓ ACTIVE	Treatment	Draft	07 May 16:15	Detail Edit
cognitive training: online programs	✓ ACTIVE	Treatment	Draft	07 May 16:15	Detail Edit
combination medication	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
comfort care earliest documentation timepoint type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
comfort care indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
comfort care measure other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
comfort care measure type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
complication surgery procedure aneurysm treatment type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
compression device type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
compression device type worn during examination indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
compressive therapy score	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
concern risks reason for stop other female hormones	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
concomitant procedures performed	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
concurrent injury treatment after concussion duration	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
concurrent injury treatment after concussion indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
concurrent injury treatment after concussion specify text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
concurrent medication prescribed or changed	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
Concurrent Non-study Medication (including key background medication)	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
congenital deformity surgery caused description	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
constipating agent fecal incontinence drug last four week indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
contraceptive counseling was provided	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
contraceptive hormone replacement treatment counsel indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
contraceptive hormone replacement treatment intervention type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
controlled substances act (csa) - federal control status	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
coronary artery catheterization phenx	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
coronary cath intervention phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
corticosteroid injection	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
corticosteroids	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
counseling to achieve pregnancy was provided	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
covid-19 complication occurrence indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
covid-19 complication onset date	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
covid-19 complication onset date indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
covid-19 complication specify other type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
covid-19 specific medication specify other type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
covid-19 specific medications occurrence indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
covid-19 treatment or device specify other type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
covid-19 treatment or device type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
cranial surgery prior indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
craniectomy perform indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
craniocervical fusion indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
cream or ointment containing cortisone	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
cream/jellies for menopausal symptoms	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
current chemo/radiation for cancer	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
current condition of cancer: treatment, remission, cured	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
currently in treatment for cancer	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
cv catheter history: placement date and time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
cv catheter history: previous placement	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
cv catheter history: removal date and time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
cv catheter history: site	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
cv catheter history: type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
cyclophosphamide	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
cyclosporine	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
daily aspirin phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
date began	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
date consented for ad treatment trial	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
date ended	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
date of last blood product transfusion	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
date of medication collection	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
date of most recent rbc transfusion	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
date of second infusion of hematopoietic cells	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
date when first prescribed glasses lens prescription [phenx]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
day/week/month	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
definitive clinical care post trauma location other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
definitive clinical care post trauma location type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
degenerative spine disorder surgery caused indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device discontinuation reason	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device implanted amperage value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device implanted comment text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device implanted implant date and time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device implanted intolerable stimulation adverse effect modification description text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device implanted left extension revision component type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device implanted left lead revision component type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device implanted modification other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device implanted modification reason	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device implanted nerve stimulator new component model number	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device implanted nerve stimulator new component registration number	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device implanted nerve stimulator revision component type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device implanted new lead component model number	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device implanted other adverse effect modification description text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device implanted other revision component type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device implanted positive electrode count	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device implanted positive electrode location text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device implanted pulse width value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device implanted removal date	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device implanted revision component model number	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device implanted revision component type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device implanted revision modification date	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device implanted revision modification type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device implanted revision or replacement other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device implanted revision or replacement reason	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device implanted right extension revision component type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device implanted serious adverse effect modification description text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device implanted stimulation off duration	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device implanted stimulation on duration	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device implanted type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device implanted voltage value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device neurostimulator anatomic other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device neurostimulator anatomic site	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device part left in the body indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device permanent explant date	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device start date and time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device stimulation target anatomic other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
device stimulation target anatomic site	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
diabet retinop laser surg times phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
diabetes medicine type phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
diabetes or high blood sugar: treated in last 12 months?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
diabetes treated with: diet	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
diabetes treated with: insulin	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
diabetes treated with: oral medications	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
diabetes treated with: unknown	✓ NACC_csv	Treatment	Draft	07 May 16:15	Detail Edit
diabetes treatment type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
diabetic retinopathy surgery ever phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
did (he/she) ever have an operation to straighten (his/her) eyes?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
did anyone from your child’s health plan, doctor’s office, or clinic help you get this therapy for your child?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
did anyone from your child’s health plan, doctor’s office, or clinic help you get this treatment or counseling for your child?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
did the deviation/violation result in the discontinuation of study therapy?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
did the patient receive dialysis?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
did the patient receive g-csf during this assessment period?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
did the patient receive hydroxyurea during this reporting period?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
did the patient require mechanical ventilation?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
did the patient withdraw consent to receive investigational study drug?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
did the patient's anc drop below 500/μl after the initiation of the conditioning regimen?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
did this relative have this strabismus treament [phenx]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
did you have a blood transfusion before 1993?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
did you or your partner ever go to a doctor or other medical care provider to talk about ways to help you have a baby together [phenx]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
did you receive this treatment for your glaucoma [phenx]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
did you stop the regular use of any of the following medications during the past 3 years? 'baby' or low-dose aspirin.	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
did your menstrual periods stop because of medication, chemotherapy, or radiation?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
dietary intervention type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
dietary recommendation indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
dietary supplement brand formulation name	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
dietary supplement compounded formulation ingredient text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
dietary supplement generic name	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
dietary supplement study use indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
dietician consult past year count	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
dietician consult past year indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
discipline types	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
discuss stopping other female hormones with doctor	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
do not resuscitate or intubate (dnr or dni) indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
do you currently take any of the following pain-relieving medications regularly (at least once a week)? 'baby' or low-dose aspirin.	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
do you currently use artificial tears or prescription medication for dry eyes regularly for 3 months or longer [phenx]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
do you get regular blood transfusions for your sickle cell disease?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
do you have a pacemaker?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
do you have an implanted pump for medication?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
do you have any other metal in your body that cannot be removed?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
do you have any rods, plates, screws, or pins in your bones or joints?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
do you take cortisone, prednisone, other steroids, or anticancer drugs, or have you had radiation treatments [phenx]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
do you take pain medicine every day for your sickle cell disease?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
doctor who prescribed other female hormones	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
documented rescue interventions [ahrq]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
does r have additional meds	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
does r have any medication allergies	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
does r take calcium supplement?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
does r take multivitamin supplement?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
does r take multivitamin?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
does respondent take calcium supplement?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
does respondent take multivitamin?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
does the patient (even if surgically sterilized) agree to practice effective barrier contraception, or agree to practice true abstinence from the time of signing informed consent through 12 months post-transplant?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
does the patient agree either (1) to practice 2 effective methods of contraception at the same time, or (2) to practice true abstinence when this is in line with the preferred and usual lifestyle of the subject, from the time of signing of informed consent through 12 months post-transplant?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
does your child currently need or use medicine prescribed by a doctor (other than vitamins)?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
does your child need or get special therapy such as physical, occupational, or speech therapy?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
dosage unit	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
dose	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
dose form - rxnorm rxcui of medication	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
dose form of medication	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
drug treatment program phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
dual x-ray absorptiometry current corticosteroid use indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
dual x-ray absorptiometry past corticosteroid use indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
durable medical equipment indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
durable medical equipment other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
durable medical equipment type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
dural additional closure agent type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
dural closure technique type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
duration of anesthesia	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
during the past y, have you received a transfusion of blood or blood products, or have you been given immune gamma globulin or an antiviral drug [phenx]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
during this pregnancy, did you receive help with an alcohol or drug problem [phenx]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
dynamic lower extremity stretch orthosis splint frequency use laterality type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
dynamic lower extremity stretch orthosis splint use anatomic site	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
dynamic lower extremity stretch orthosis splint use anatomic site laterality type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
dynamic lower extremity stretch orthosis splint use frequency type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
dynamic upper extremity orthosis splint frequency use laterality type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
dynamic upper extremity orthosis splint use anatomic site	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
dynamic upper extremity orthosis splint use anatomic site laterality type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
dynamic upper extremity orthosis splint use frequency type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ear nose throat condition medication current indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ear nose throat condition medication past year indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ear operation phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
eeg medication concomitant dose rate	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
eeg medication concomitant type other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
elbow wrist orthosis type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
elective procedure	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
electrode brain count	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
emotional psychological therapies psychotherapy indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
emotional psychological therapies psychotherapy session number	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
end age of osteoporosis medication	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
end age of osteoporosis medication 2.	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
end age of osteoporosis medication 3.	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
end date (month)	✓ NACC_csv	Treatment	Draft	07 May 16:15	Detail Edit
end date (year)	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
end of case extubated indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
endocrine/metabolic conditions - currently on thyroid replacement medication	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
endometriosis reason for other female hormones	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
endovascular complication intra surgery procedure type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
endovascular intervention result raymond roy grade	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
endovascular surgery procedure duration	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
energy healing frequency (12 months)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
enteric coated aspirin tablet	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
estimate the number of units (pints) of blood that you have ever received. (select one).	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
estrogen admin method cts	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
etanercept	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
etretinate	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ever attended eating problems group	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
ever attended emotional problems group	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
ever attended substance problems group	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
ever been immunized for mumps	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
ever been immunized for tetanus and diphtheria	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
ever estrogen cts	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ever had blood transfusion before	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ever had surgery to improve blood flow in legs for claudication or peripheral arterial disease	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ever premarin cts	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ever progesterone progestin cts	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ever taken high blood pressure medicine	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ever treated by a doctor or a nurse with shots at home or as an outpatient for deep vein thrombosis	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ever tried to quit smoking	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
examination day cardiovascular function medication other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
exercise/movement therapy frequency (12 months)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
exertion therapy indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
external ventricular drain clamp duration	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
extracranial venous thromboembolism prophylaxis other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
extracranial venous thromboembolism prophylaxis type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
eye condition medication past year indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
eye condition medication work well indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
eye muscle surgery phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
family doctor seen for healthcare	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
feeding tube	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
feeding tube-comments	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
feeding tube-onset age	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
female hormone prescript mos phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
female hormones taken currently?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
fertility drugs name and dosage	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
fertility drugs taken currently?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
fertility drugs taken in the past?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
fertility drugs total number of years	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
fever management threshold temperature value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
first age attended emotional problems group	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
five commonly used doses of premarin® can be distinguished by the color of the pill. please indicate any you have ever used and the one you used for the longest period.	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
five commonly used doses of premarin® can be distinguished by the color of the pill. please indicate any you have ever used and the one you used for the longest period. green (0.3 ).	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
foley catheter indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
follow a special diet	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
follow-up care other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
follow-up care specialist other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
follow-up care specialist type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
foot surgery indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
formula fed to infant name	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
fracture treatment phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
frequency	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
frequency of anabolic steroids used to improve muscle mass or strength in past year	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
frequency of dhea, androstenedione, or human growth hormone used to improve muscle mass or strength in past year	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
frequency of medicine or drug injection with needle during time period with highest use 12 months	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
fri pm take med not usually taken - coded for med type	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
fri pm take meds not usually taken	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
friday pm take medications not usually taken	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
full-contact practice completed date	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
functional neurosurgery bilateral procedure type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
functional neurosurgery other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
functional neurosurgery target anatomic other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
functional neurosurgery target anatomic site	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
functional neurosurgery target planning method other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
functional neurosurgery type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
gastrointestinal therapy continuous feed end time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
gastrointestinal therapy continuous feed formula rate	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
gastrointestinal therapy continuous feed start time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
gastrointestinal therapy daily feed value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
gastrointestinal therapy estimate caloric intake value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
gastrointestinal therapy feed method type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
gastrointestinal therapy feed schedule table number	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
gastrointestinal therapy feed tube first place date	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
gastrointestinal therapy feed tube other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
gastrointestinal therapy feed tube placement method type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
gastrointestinal therapy feed tube type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
gastrointestinal therapy feed type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
gastrointestinal therapy formula grade	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
gastrointestinal therapy formula name	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
gastrointestinal therapy fundoplication age value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
gastrointestinal therapy fundoplication date	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
gastrointestinal therapy fundoplication indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
gastrointestinal therapy nutrition supplement other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
gastrointestinal therapy nutrition supplement type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
gastrointestinal therapy other oral intake estimate caloric value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
gastrointestinal therapy other oral intake text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
gastrointestinal therapy received indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
gastrointestinal therapy take nutrition supplement indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
gastrointestinal therapy water flush status	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
gastrointestinal tract surgical procedure indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
gastrointestinal tract surgical procedure other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
gaucoma drops name phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
gender of doctor prescribed other female hormones	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
general anesthesia indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
general anesthesia indicator count	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
general anesthesia text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
general anesthesia time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
general rehabilitation center follow-up care indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
genetic counseling provided	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
getting the medicine i need	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
getting treatment for heart trouble now	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
gingko biloba for menopausal symptoms	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
glaucoma drops currently phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
glaucoma tx ever phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
glp-1 receptor agonists	✓ NACC_csv	Treatment	Draft	07 May 16:15	Detail Edit
go to hospital for heart treatment/tests	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
growth hormone treatment indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
gut condition medication past year indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
had urgent care (12 mo)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
had gallbladder surgery phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
had orthodontic treatment phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
had ovary removed (one, both, none)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
had scheduled treat/surgery (12 months)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
had scheduled treat/surgry (12 mo)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
hand orthosis type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
has the child ever been treated in the past for this vision problem [phenx]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
has the participant ever been prescribed a treatment or been enrolled in a clinical trial of a treatment expected to modify adrd biomarkers?	✓ NACC_csv	Treatment	Draft	07 May 16:15	Detail Edit
has the participant ever experienced amyloid related imaging abnormalities-edema (aria-e), amyloid related imaging abnormalities-hemorrhage (aria-h), or other major adverse events associated with treatments expected to modify adrd biomarkers?	✓ NACC_csv	Treatment	Draft	07 May 16:15	Detail Edit
has the participant taken female hormone replacement pills or patches (e.g. estrogen)?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
has the patient achieved rbc transfusion independence (no transfusion in the past 6 months)?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
has the patient had a second infusion of hematopoietic cells (with or without preparative regimen)?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
has the patient received >= 8 packed red blood cell (rbc) transfusions per year for >= 1 year in the 12 months before enrollment to prevent vaso-occlusive clinical complications (i.e. pain, stroke, and acute chest syndrome)?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
has the patient received a prior solid organ transplant?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
has your baby's physician or other health care professional discussed the following management options with you?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
have you been treated for pneumonia	✓ ACTIVE	Treatment	Draft	07 May 16:15	Detail Edit
have you completed the covid-19 vaccination course? most covid-19 vaccines require two shots.	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
have you ever been immunized for hepatitis b?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
have you ever been immunized for pneumonia?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
have you ever been immunized for shingles?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
have you ever had a kidney transplant [phenx]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
have you ever had a tube placed in your ear to drain the fluid from your ear [phenx]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
have you ever had immunosuppressive therapy?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
have you ever had medical treatment to dissolve or remove gallstones [phenx]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
have you ever had radiation therapy to your head or neck?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
have you ever had surgery?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
have you ever had treatment for heart trouble in the past 10 years?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
have you ever received a flu vaccination?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
have you ever received any medication for osteoporosis treatment?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
have you ever required medicine or treatment for the(se) attack(s)?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
have you ever taken birth control pills?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
have you ever taken medication for high blood cholesterol?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
have you ever taken medication to treat seizure or epilepsy?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
have you ever taken prednisone?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
have you ever taken prescription medication for headache on a daily basis, whether or not you have a headache, to help prevent a severe headache from happening in the first place?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
have you ever worn a patch or used eye drops (atropine penalization) for eye correction?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
have you had a penile implant?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
have you had an outpatient or day surgery procedure to unblock blocked or narrowed blood vessels of the heart?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
have you had any treatment for high blood pressure (hypertension) in the past 10 years?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
have you had surgery or other repair for this aneurysm?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
have you participated in any clinical trials or do you currently receive medications to treat symptoms related to dmd?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
have you received a covid-19 vaccine?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
have you received a flu vaccine this season (last 6 months)?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
have you received any vaccinations in the past 4 weeks [phenx]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
headache migraine rescue device used name	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
headache or migraine medication taken other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
headache pain medication after study drug indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
headache pain medication more than four days week indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
headache pain relief factor type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
headache post initial study medication date and time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
headache post initial study medication time interval	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
headache prior treatment indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
headache re-start medication taken other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
headache re-start medication taken time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
headache re-start pain medication indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
health conditions - medication or other treatments	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
hearing aid	✓ ACTIVE	Treatment	Draft	07 May 16:15	Detail Edit
heart disease: treated in last 12 months?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
hematoma evacuate surgery procedure indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
hemodynamic augmentation indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
hemodynamic augmentation specify text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
hemodynamic therapy indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
hemodynamic therapy specify text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
heparin monitored	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
heparin monitoring end date and time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
heparin monitoring start date and time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
herbal therapy frequency (12 months)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
hfs code	✓ ACTIVE	Treatment	Draft	07 May 16:15	Detail Edit
high alcohol consumption avoid counsel indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
high alcohol consumption avoid intervention type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
high blood pressure or hypertension: treated in last 12 months?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
high blood pressure therapy - diet	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
high blood pressure therapy - exercise	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
high blood pressure therapy - herbal	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
high blood pressure therapy - meditation/relaxation	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
high blood pressure therapy - other	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
high blood pressure therapy - other (enter treatment)	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
high blood pressure therapy - vitamins/minerals	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
high cholesterol treatment type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
high cholesterol: treated in last 12 months?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
high dose mega-vitamins frequency (12 months)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
high sodium intake avoid counsel indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
high sodium intake avoid intervention type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
highest level of oxygen support received on study day	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
history of severe bleeding related to aspirin use	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
history of surgical procedures	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
home medical equipment indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
home medical equipment other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
homeopathic seen for healthcare	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
homeopathic therapies	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
homeopathy frequency (12 months)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
hormonal therapy medication device dose frequency text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
hormone replacement therapy - has the participant received hrt?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
hormone therapy current former receive age start value	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
hormone therapy current former receive duration	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
hormone therapy current former type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
hormone therapy duration	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
hormone therapy name	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
hormone therapy type	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
hormone treatment	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
hospital care upon admission type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
hospital overnight for other injury/illness a	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
hospitalization non-surgical elective indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
hospitalization non-surgical ventilation indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
hot flashes reason for other female hormones	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
how birth control method was provided	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how long has your current anti-anxiety prescription been stable (same medication, frequency, dose)?... months	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
how long has your current anti-depressant prescription been stable (same medication, frequency, dose)? ... months	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
how long has your current aripiprazole (abilify) prescription been stable (same frequency and dose)?... months	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
how long has your current donepezil (aricept) prescription been stable (same frequency and dose)?... months	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
how long has your current galantamine (razadyne) prescription been stable (same frequency and dose)?... months	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
how long has your current memantine (namenda) prescription been stable (same frequency and dose)?... months	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
how long has your current olanzapine (zyprexa) prescription been stable (same frequency and dose)?... months	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
how long has your current paliperidone (invega) prescription been stable (same frequency and dose)?... months	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
how long has your current quetiapine (seroquel) prescription been stable (same frequency and dose)?... months	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
how long has your current risperidone (risperdal) prescription been stable (same frequency and dose)?... months	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
how long has your current rivastigmine (exelon) prescription been stable (same frequency and dose)?... months	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
how long has your current tacrine (cognex) prescription been stable (same frequency and dose)?... months	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
how long was the participant on treatment?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how many specialists has your child seen in the last 6 months?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how many times have you been treated with steroid pills or injections, such as prednisone or solumedrol, for a chest illness [phenx]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how many times have you had to be treated with antibiotics for a chest illness [phenx]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how many times have you required antibiotics for a cold or pneumonia in the last year?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how many times were parenteral opioid drugs required for the painful vaso-occlusive crisis in the outpatient setting during this assessment period?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how many total tablets per week of pain-relieving medication [ca teachers]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how many years did you take b-complex or stress-tab type multiple vitamins?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how many years did you take calcium, alone or combined with something else such as in a bone health supplement or in an antacid?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how many years did you take coenzyme q-10?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how many years did you take fish oil or omega-3 fatty acids?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how many years did you take flaxseed?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how many years did you take folic acid, folate?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how many years did you take garlic, as a pill, tablet, or capsule?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how many years did you take glucosamine, alone or combined with something else?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how many years did you take iron?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how many years did you take regular one-a-day type, centrum® or thera-type multiple vitamins?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how many years did you take saw palmetto?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how many years did you take selenium?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how many years did you take vitamin b-12?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how many years did you take vitamin b-6?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how many years did you take vitamin c?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how many years did you take vitamin d, alone?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how many years did you take vitamin e?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how many years did you take zinc?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how often did you take fish oil or omega-3 fatty acids?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how often did you take iron?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how often did you take saw palmetto?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how often did you take selenium?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how often did you take vitamin b-12?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how often did you take vitamin b-6?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how often did you take vitamin c?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how often did you take vitamin d, alone?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how often did you take vitamin e?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how often did you take zinc?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how often do you get an influenza vaccination?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
how sure about 2nd open heart surgery	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
how sure choice of bypass or exercise	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
how sure would choose bypass or medication	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
how was the treatment provided?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
hpv vaccination ever	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
hpv vaccine doses received	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
hx antibiotics tx chest last y phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
hx steroid tx chest last y phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
hydrocephalus diagnosis required intervention six month indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
hypertension treatment type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
hypervolemic therapy volume augmentation indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
hypervolemic therapy volume augmentation range	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
hypervolemic therapy volume augmentation specify text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
i get embarrassed using my medication in public [phenx]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
i have unpleasant side effects from my medication [phenx]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ibuprofen	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
icd-10-cm code	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
if 'a4a ad-specific drug treatment' form was completed remotely, specify reason	✓ NACC_csv	Treatment	Draft	07 May 16:15	Detail Edit
if actual dose is known, specify here:	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
if clinical trial, in which group was the participant?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
if medication not found in search list, hand enter for approval	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
if other, specify	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
if partial, what is the participant withdrawing from?	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
if pharmacological, the mechanism of action is	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
if the patient received dialysis, were the laboratory values corrected?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
If Yes, Are you taking any pills or medicine for it?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
if yes, how many hours a day?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
if yes, how often do you use nebulizer?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
if yes, specify additional agents administered	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
if yes, surgery date	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
if you used provera®, what was your usual dose?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
imaging intra-operative type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
imaging magnetoencephalography evoked field acquisition sedation type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
imaging magnetoencephalography sedation anesthesia type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
imaging medication pre-treatment status	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
imaging medication pre-treatment withheld duration	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
imaging transcranial magnetic stimulation pulse frequency	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
imaging transcranial magnetic stimulation technique type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
immune disorder treatment received indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
immunization status	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
immunomodulating agent other specify	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
immunosuppressant (prophylaxis) received	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
immunosuppressant specify	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
implanted pulse generator replaced number	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
improve memory reason for other female hormones	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
in the last 6 months, did you get or refill any prescription medicines for your child?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
in the last 6 months, did you get or try to get special therapy such as physical, occupational, or speech therapy for your child?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
in the last 6 months, did you get or try to get treatment or counseling for your child for an emotional, developmental, or behavioral problem?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
in the last 6 months, did you try to get any kind of care, tests, or treatment for your child through his or her health plan?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
in the last 6 months, did your child get care from more than one kind of health care provider or use more than one kind of health care service?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
in the last 6 months, did your child’s doctor or other health provider talk with you about the pros and cons of each choice for your child’s treatment or health care?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
in the last 6 months, how often was it easy to get this therapy for your child?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
in the last 6 months, how often was it easy to get this treatment o r counseling for your child?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
in the last 6 months, when there was more than one choice for your child’s treatment or health care, did your child’s doctor or other health provider ask you which choice was best for your child?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
in the past 12 months, how many times has he or she seen an eye doctor for his or her myopia, nearsightedness [phenx]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
in the past 12 months, what is the longest you had to wait in the emergency room before your sickle cell pain was treated?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
in the past 30 days have you taken testosterone for sexual activity?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
in the past 30 days have you used a vaginal dilator?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
in the past 30 days have you used hormones (for example, estrogen, testosterone, or progesterone) for sexual activity either as a patch on your skin, or a cream, tablet, or ring inserted into your vagina?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
in the past 30 days how often have you taken a pill such as viagra, cialis, or levitra for sexual activity?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
in the past 30 days how often have you used a vacuum pump (penis pump) to get an erection?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
in the past 30 days how often have you used an injection into your penis to get an erection?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
in the past 30 days how often have you used vaginal moisturizers (such as replens)?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
in the past 7 days, when i was in pain i asked for medicine.	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
in vivo immunotoxin	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
in what year was this surgery a performed?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
in what year was this surgery b performed?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
in what year was this surgery c performed?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
in what year was this surgery d performed?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
in what year was this surgery e performed?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
in what year was this surgery f performed?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
in what year was this surgery i performed?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
incorrect action [ahrq]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
increase intracranial pressure medical therapy type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
indicate treatment modification	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
infection condition medication currently indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
infection condition medication name	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
infection condition medication past year indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
infection condition medication work well indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
influenza vaccine first receive age value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
influenza vaccine history indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
infusion related reaction	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ingredient - rxnorm rxcui of medication	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ingredients for compounded preparations medication	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
injection site laterality type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
injury immediate medical service receive indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
injury immediate medical service received other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
injury immediate medical service received type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
injury treatment hospital prior study center indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
inpatient final discharge date and time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
inpatient therapy or rehabilitation location type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
inpatient treatment total day number	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
insulin injection daily count	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
insulin miss dose past two week count	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
insulin neutral protamine hagedorn current use indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
insulin pen use indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
insulin premix current use indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
insulin was taken in last 8h 8 hour	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
intended therapy duration (days)	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
internist seen for healthcare	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
intervention endovascular status	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
intervention surgical status	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
interventionprocedure date	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
intra-arterial (ia) catheter-based reperfusion initiated date and time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
intra-arterial (ia) catheter-based reperfusion other hospital indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
intra-arterial (ia) procedure groin puncture date and time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
intra-arterial (ia) procedure initiated indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
intra-sinus intervention groin puncture date and time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
intra-sinus intervention indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
intra-sinus intervention initiated date and time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
intra-sinus procedure type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
intracranial hypertension cerebral edema osmotherapy indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
intracranial hypertension cerebral edema osmotherapy specify text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
intracranial pressure catheter anatomic site	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
intracranial pressure catheter anatomic site other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
intracranial pressure catheter revised indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
intracranial pressure device type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
intracranial pressure monitoring stop date and time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
intracranial pressure monitoring stopped reason	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
intracranial pressure treatment threshold value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
intracranial procedure other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
intracranial procedure type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
intracranial procedure type other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
intracranial revascularization procedure other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
intracranial revascularization procedure type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
intracranial surgery indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
investigational or experimental protocol for thrombolysis indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
investigational or experimental protocol for thrombolysis text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
investigator assessment concomitant medication specify text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
investigator assessment intervention withdrawal specify text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
is the medication continuing?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
is the participant currently being treated for this (e.g., cpap)?	✓ NACC_csv	Treatment	Draft	07 May 16:15	Detail Edit
is the participant currently taking any medications?	✓ NACC_csv	Treatment	Draft	07 May 16:15	Detail Edit
is the patient currently receiving >= 8 packed red blood cell transfusions per year for >= 1 year or has the patient received >= 20 packed red blood cell transfusions (lifetime cumulative)?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
is this a surgery?	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
is this because of any medical, behavioral, or other health condition?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
is your baby currently receiving support from any of the following specialties?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
is your baby receiving care in a neuromuscular clinic?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
iv tpa at another hospital indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
iv tpa initiated date and time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
iv tpa initiated status	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
iv tpa not started mri selection treatment beyond 4.5 hour reason	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
iv tpa not started other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
iv tpa not started reason	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
kiddie-schedule for affective disorders and schizophrenia-present and lifetime version (k-sads-pl) - antidepressant medication history indicate code	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
kiddie-schedule for affective disorders and schizophrenia-present and lifetime version (k-sads-pl) - antidepressant medication history text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
kiddie-schedule for affective disorders and schizophrenia-present and lifetime version (k-sads-pl) - antipsychotic medication history indicate code	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
kiddie-schedule for affective disorders and schizophrenia-present and lifetime version (k-sads-pl) - antipsychotic medication history text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
kiddie-schedule for affective disorders and schizophrenia-present and lifetime version (k-sads-pl) - lithium history text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
kiddie-schedule for affective disorders and schizophrenia-present and lifetime version (k-sads-pl) - lithium medication history indicate code	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
kiddie-schedule for affective disorders and schizophrenia-present and lifetime version (k-sads-pl) - other medication history text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
kiddie-schedule for affective disorders and schizophrenia-present and lifetime version (k-sads-pl) - outpatient ever history indicate code	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
kiddie-schedule for affective disorders and schizophrenia-present and lifetime version (k-sads-pl) - outpatient treatment first age value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
kiddie-schedule for affective disorders and schizophrenia-present and lifetime version (k-sads-pl) - stimulant history text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
kiddie-schedule for affective disorders and schizophrenia-present and lifetime version (k-sads-pl) - stimulant medication history indicate code	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
l-dopa post-operative stim - off time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
l-dopa post-operative stim - on time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
l-dopa pre-operative stim-off time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
l-dopa pre-operative stim-on time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
lamprene	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
last took daily med phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
lead implanted pulse generator model other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
lead implanted pulse generator model type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
lead repositioned indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
lead repositioned other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
lead repositioned reason	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
lesion procedure(s) performed	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
light aerobic exercise reahbilitation stage completed date	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
lipid lower agent stroke discharge prescribe other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
lipid lower agent stroke discharge prescribe type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
location of cast or medical prosthesis	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
lose 10 pounds by diet or exercise	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
lumbar drain indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
lung condition medication currently indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
lung condition medication name	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
lung condition medication past year indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
lung condition medication work well indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
major surgical procedure - upper-extremity orthopedic surgery	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
major surgical procedures - adult cardiac surgery	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
major surgical procedures - other surgery	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
major surgical procedures - thyroid surgery	✓ NACC_pdf	Treatment	Draft	07 May 16:15	Detail Edit
manufacturer name of medication	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
maraviroc	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
matched with lexicon generic name	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
maternal treatment for affected fetus	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
mechanical balloon angioplasty adverse clinical exam change indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
mechanical balloon angioplasty intra-arterial indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
mechanical balloon angioplasty procedural adverse event other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
mechanical balloon angioplasty procedural adverse event type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
mechanical in/ex-sufflation (cough assist)	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
mechanical prophylaxis brand name	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
mechanical prophylaxis indication	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
mechanical prophylaxis indication: other	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
mechanical prophylaxis treatment goal	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
mechanical prophylaxis type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
mechanical prophylaxis type: other	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
mechanical ventilation utilization frequency	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
med ahfs description	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
med strength medication.current phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medical device - device type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medical foods/special diet	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medical history artificial valve type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medical history asthma pulmonary inhalers use indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medical history bilevel positive airway pressure ventilator since last visit indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medical history carotid artery stenting anatomic site	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medical history carotid artery stenting recent date	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medical history carotid endarterectomy anatomic site	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medical history cough assist since last visit indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medical history gastrostomy tube since last visit indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medical history intubated since last visit indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medical history non-invasive ventilation adjusted setting text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medical history non-invasive ventilation setting type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medical history other surgery since last visit indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medical history physical therapy change since last visit frequency	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medical history physical therapy change since last visit indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medical history pulmonary antibiotics use frequency	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medical history pulmonary bilevel positive airway pressure frequency	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medical history pulmonary bilevel positive airway pressure indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medical history pulmonary cough assist status	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medical history pulmonary current intermittent positive pressure breathing use status	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medical history respiratory support type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medical history scoliosis surgery since last visit indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medical history speech therapy since last visit frequency	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medical history speech therapy since last visit indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medical history test sedation require indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medical history tracheostomy since last visit indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medical history ventilator adjusted setting text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medical history ventilator setting type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medical office visit diabetes past year count	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
medical reason why you had or have to take this medication [phenx]	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
medical with home care supplement	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
medical with hospital supplement	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
medication	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication ace inhibitor past week other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication actual use schedule frequency	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
medication adhd add current former take indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication adjusted frequency	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication affect sleep stop indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication affecting bowel function constipating agent other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication affecting cardiovascular function type exam day indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication and supplement comments	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication angiotensin receptor blocker past week other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication angiotensin receptor blocker past week type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication anti-epileptic drug appropriate indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication anti-epileptic drug dose adjustment attempt indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication anti-epileptic drug formulation indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication anti-epileptic drug log line number	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication anti-epileptic drug name	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication anti-epileptic drug plasma concentration log comment text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication anti-epileptic drug plasma concentration log line number	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication anti-epileptic drug seizure despite adjustment indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication anti-epileptic drug three months therapy without discontinuation indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication anti-parkinsonian added after surgery indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication anti-parkinsonian during procedure indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication anti-parkinsonian reduced after surgery indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication anti-parkinsonian reduced after surgery percent value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication anticoagulant current former take age start value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication anticoagulant current former take duration	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication anticoagulant current former take other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication anticoagulant current former type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication anticoagulant former take age end value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication anticoagulant past week other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication anticoagulant past week type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication antihypertensive current former other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication antihypertensive current former take age start value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication antihypertensive current former take duration	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication antihypertensive current former take indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication antihypertensive current former type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication antihypertensive former take age end value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication antihypertensive past week type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication antiplatelet current former other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication antiplatelet current former take age start value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication antiplatelet current former take duration	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication antiplatelet current former type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication antiplatelet former take age end value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication antiplatelet past week other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication antiplatelet past week type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication antithrombotic used procedure type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication audit administered, specify	✓ ACTIVE	Treatment	Draft	07 May 16:15	Detail Edit
medication audit completed at this visit	✓ ACTIVE	Treatment	Draft	07 May 16:15	Detail Edit
medication baseline modification before study start indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication beta-blocker past week type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication calcium-channel blocker past week other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication calcium-channel blocker past week type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication cardiovascular function exam day indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication cardiovascular function other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication cardiovascular function type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication cholesterol reduce control past week other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication cold preparation current former take indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication diabetic past week other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication diabetic past week type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication discontinuation dose related side effect text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication discontinuation idiosyncratic side effect text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication diuretic past week other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication dosing schedule administration time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication generic or brand type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication help sleep problem indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication history date	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
medication hormone replacement current former take indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication hormone replacement therapy route other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication immunosuppressant current former take age start value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication immunosuppressant current former take duration	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication immunosuppressant current former take other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication immunosuppressant current former type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication immunosuppressant former take age end value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication implant estrogen contraceptive current former take indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication initial dose	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication initial frequency	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
medication interfere life phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication name	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
medication non-anti-epileptic drug log line number	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication non-anti-epileptic drug prior or concomitant dose frequency	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication non-anti-epileptic drug prior or concomitant use day count	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication not help phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication or other substance was involved [ahrq]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication or substance contraindication - potential or actual interaction [ahrq]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication or substance was given [ahrq]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication or substance was prescribed [ahrq]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication other antihypertensive past week text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication other current former take indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication other past week other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication over the counter indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication plasma concentration blood draw date and time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication plasma concentration last dose date and time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication plasma concentration last dose unit of measure ucum code	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication plasma concentration last dose value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication plasma concentration medication name	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication plasma concentration no adherence clinically significant indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication plasma concentration result	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication plasma concentration result unit of measure	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication plasma concentration result unit of measure ucum code	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication prior concomitant dose frequency clinical data interchange standards consortium standard data tabulation model code	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication prior or concomitant discontinuation other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication prior or concomitant discontinuation reason	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication prior or concomitant dose	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication prior or concomitant dose frequency	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication prior or concomitant dose frequency other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication prior or concomitant formulation text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication prior or concomitant indication text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication prior or concomitant prn average monthly frequency	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication prior or concomitant response text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication prior or concomitant route other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication prior or concomitant rxnorm code	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication prior or concomitant use indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication prior total daily as needed dose measure	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication reduce blood sugar prior diagnosis indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication reduce blood sugar prior diagnosis name	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication side effect or complication indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication statin current former take age start value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication statin current former take duration	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication statin current former type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication statin former take age end value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication stopped menstrual period	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
medication stopped other instructions given specify text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication strength	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
medication stroke discharge prescribe category	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication supplement indication text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication supplement name	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication symptom status	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication time and date [phenx] --pre excercise	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication type: prescription or quasi	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication type: prescription, otc, or alternative	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
medication withheld duration	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication withheld prior sample collection name	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
medication withheld prior to sample collection indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
meds or creams containing cortisone	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
menopause treatment type	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
menopause treatment type other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
mental resilience stress management tool adopt counsel indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
mental resilience stress management tool adopt intervention other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
mental resilience stress management tool adopt intervention type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
method of taking (route) 1	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
methotrexate	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
mitochondrial disease alternative medicine treat gi problem indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
mitochondrial disease alternative medicine treatment improve gi problem text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
mitochondrial disease alternative medicine treatment worsen gi problem text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
mitochondrial disease bowel movement treatment efficacy text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
mitochondrial disease defecation other treatment text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
mitochondrial disease delay treatment gi problem indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
mitochondrial disease liquid diet text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
mitochondrial disease medication gi problem worsen text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
mitochondrial disease medication other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
mitochondrial disease past restrict diet indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
mitochondrial disease prior bowel movement other treatment text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
mitochondrial disease special diet reason text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
mmf	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
mon am did you take sleep med or supplement	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
mon pm take meds not usually taken	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
monitoring intraprocedural physiological indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
month first ovary removed	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
month had hysterectomy	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
month last immunized for hepatitis b	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
month last immunized for pneumonia	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
month last immunized for tetanus and diphtheria	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
month second ovary removed	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
month stop taking other female hormones	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
most seen healthcare professional	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
most treatment medication phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
most treatment y phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
movement disorder society - unified parkinson's disease rating scale (mds updrs) - patient on medication for parkinson indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
multiple application indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
multiple sclerosis, epilepsy, or other neurological disorders: treated in last 12 months?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum drug id	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum phamacologic category #1	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum phamacologic category #2	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum phamacologic category #4	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum phamacologic category #5	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1050 - antidepressant selective serotonin reuptake inhibitor: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1050 - antidepressant selective serotonin reuptake inhibitor: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1074 - antidote: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1074 - antidote: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1156 - antihypertensive: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1156 - antihypertensive: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1171 - antilipemic agent hmg coa reductase inhibitor: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1171 - antilipemic agent hmg-coa reductase inhibitor: yes/no?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1177583 - histamine h1 antagonist second generation: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1177583 - histamine h1 antagonist second generation: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1225 - antiplatelet agent: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1225 - antiplatelet agent: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1291 - beta-blocker, beta-1 selective: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1291 - beta-blocker, beta-1 selective: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1299 - beta 2 agonist: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1299 - beta2 agonist: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1313 - calcium channel blocker: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1313 - calcium channel blocker: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1314 - calcium salt: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1314 - calcium salt: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1428 - dietary supplement: how many?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1428 - dietary supplement: yes/no?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1439 - diuretic thiazide: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1439 - diuretic thiazide: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1447 - electrolyte supplement oral: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1447 - electrolyte supplement oral: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1602 - nonsteroidal anti-inflammatory drug (nsaid), oral: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1602 - nonsteroidal anti-inflammatory drug (nsaid), oral: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1603 - nonsteroidal anti-inflammatory drug (nsaid), parenteral: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1603 - nonsteroidal anti-inflammatory drug nsaid parenteral: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1629 - phosphate binder: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1629 - phosphate binder: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1651 - proton pump inhibitor: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1651 - proton pump inhibitor: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1665 - salicylate: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1665 - salicylate: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1710 - thyroid product: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1750 - vitamin: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1750 - vitamin: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1752 - vitamin d analog: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1752 - vitamin d analog: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1753 - vitamin fat soluble: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1753 - vitamin fat soluble: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1756 - vitamin water soluble: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1756 - vitamin water soluble: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1768 - histamine h1 antagonist: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1768 - histamine h1 antagonist: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1797080 - calcium channel blocker, dihydropyridine: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1797080 - calcium channel-blocker, dihydropyridine: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1824 - substituted benzimidazole: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 1824 - substituted benzimidazole: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 3974202 - antilipemic agent, omega-3 fatty acids: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 3974202 - antilipemic agent, omega-3 fatty acids: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 5251182 - medical food: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 5251182 - medical food: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 946 - analgesic, opioid: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 947 - analgesic nonopioid: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 947 - analgesic nonopioid: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 957 - angiotensin converting enzyme (ace) inhibitor: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 957 - angiotensin converting enzyme ace inhibitor: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 958 - angiotensin ii receptor blocker: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 958 - angiotensin ii receptor blocker: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 961 - antacid: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 961 - antacid: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 971 - antianginal agent: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category 971 - antianginal agent: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum pharmacologic category number	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic class #2	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic class #3	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic class 115 - nutritional products: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic class 115 - nutritional products: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic class 122 - respiratory agents: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic class 122 - respiratory agents: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic class 133 - topical agents: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic class 133 - topical agents: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic class 218 - alternative medicines: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic class 218 - alternative medicines: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic class 242 - psychotherapeutic agents: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic class 242 - psychotherapeutic agents: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic class 358 - metabolic agents: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic class 358 -metabolic agents: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic class 40 - cardiovascular agents: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic class 40 - cardiovascular agents: yes/no?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic class 57 - central nervous system agents: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic class 57 - central nervous system agents: yes/no?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic class 81 - coagulation modifiers: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic class 81 - coagulation modifiers: yes/no?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic class 87 - gastrointestinal agents: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic class 87 - gastrointestinal agents: yes/no?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic class 97 - hormones/hormone modifiers: how many?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic class 97 - hormones/hormone modifiers: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic class number	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic sub-class 101 - sex hormones: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic sub-class 117 - minerals and electrolytes: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic sub-class 119 - vitamins: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic sub-class 120 - vitamin and mineral combinations: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic sub-class 123 - antihistamines: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic sub-class 125 - bronchodilators: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic sub-class 136 - dermatological agents: yes/no?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic sub-class 19 - antihyperlipidemic agents: yes/no?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic sub-class 219 - nutraceutical products: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic sub-class 220 - herbal products: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic sub-class 247 - nasal preparations: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic sub-class 272 - proton pump inhibitors: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic sub-class 42 - angiotensin converting enzyme inhibitors: yes/no?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic sub-class 47 - beta-adrenergic blocking agents: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic sub-class 48 - calcium channel blocking agents: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic sub-class 49 - diuretics: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic sub-class 55 - antihypertensive combinations: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic sub-class 56 - angiotensin ii inhibitors: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic sub-class 58 - analgesics: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic sub-class 64 - anticonvulsants: yes/no?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic sub-class 67 - anxiolytics sedatives and hypnotics: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic sub-class 83 - antiplatelet agents: yes/no?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic sub-class 88 - antacids: yes/no?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic sub-class 99 - antidiabetic agents: yes/no?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic sub-class number 1 for tc1	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
multum therapeutic sub-class number 1 for therapeutic class 1 (tc1)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
myasthenia gravis treatment type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
mycophenolate mofetil (mmf, cellcept)	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
myopia treatment phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
name of procedure?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
national institutes of health stroke scale (nihss) supplemental - intervention present type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
neural element direct decompression indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
neuromuscular scoliosis surgery treat indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
new renal replacement therapy	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
no activity rehabilitation completed date	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
no one in particular seen for healthcare	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
no symptoms reason for stop other female hormones	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
non-contact rehabilitation stage complete date	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
non-steroidal anti-inflammatory drug current former take age start value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
non-steroidal anti-inflammatory drug current former take duration	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
non-steroidal anti-inflammatory drug current former type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
non-steroidal anti-inflammatory drug former take age end value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
non-surgical bed rest external immobilization indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
nonsurgical bleeding: interventions used	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
now taking high blood pressure medicine	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
now taking prescription medications for blood pressure	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
num times scheduled treat/surgry (12 mo)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
number of alternative medications	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
number of non-prescription medications	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
number of over the counter (otc) medications	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
number of prescription medications	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
number of quasi (non-prescription) medications	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
number of times counselor for mental health (12 months)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
number of times general doctor for mental health (12 months)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
number of times psychiatrist for mental health (12 months)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
number of times seeing medical doctor (12 months)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
number of times urgent care (12 months)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
number times attended emotional problems group	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
number times attended physical disabilities group	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
number times counselor for mental health (12 months)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
number times general doctor for mental health (12 months)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
number times psychiatrist for mental health (12 months)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
number times saw mental health professional (12 months)	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
number times scheduled treatment/surgery (12 months)	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
number times seeing medical doctor (12 mo)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
number times seeing medical doctor (12 months)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
number years taken birth control	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
number years taken fertility drugs	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
obstetrician/gynecologist seen for healthcare	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
occupation therapy intervention type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
occupational therapy focus area minute time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
oe-name of the birth control and the dosage starting with the most recent #1	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
oe-name of the birth control and the dosage starting with the most recent #3	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
oe-name of the birth control and the dosage starting with the most recent #4	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
oe-name of the birth control and the dosage starting with the most recent #5	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
oe-name of the birth control and the dosage starting with the most recent #6	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
oe-name of the female hormone and the dosage starting with the most recent #1	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
oe-name of the female hormone and the dosage starting with the most recent #4	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
oe-name of the female hormone and the dosage starting with the most recent #5	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
oe-name of the female hormone and the dosage starting with the most recent #6	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
oe-name of the fertility drug and the dosage starting with the most recent #1	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
oe-name of the fertility drug and the dosage starting with the most recent #4	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
oe-specialty of the doctor that prescribed the female hormones #1	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
off study intervention prematurely indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
off study intervention prematurely other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
off study intervention prematurely reason	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
on average how often do you take painkillers [phenx]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
on potential dmd modulating therapy at time of lab draw?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
on the average during the last two weeks, how many of these pills did you take a day/week/month	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
oncology surgery: specify	✓ NACC_pdf	Treatment	Draft	07 May 16:15	Detail Edit
ongoing osteoporosis medication	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
open reduction indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
open-ended (oe)-name of the birth control and the dosage starting with the most recent #1	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
open-ended (oe)-name of the female hormone and the dosage starting with the most recent #1	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
open-ended (oe)-name of the fertility drug and the dosage starting with the most recent #1	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
open-ended (oe)-specialty of the doctor that prescribed the female hormones #1	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
operation hysterectomy	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
operation removal both ovaries	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
operation removal one ovary	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
operation removal uterus and 1 ovary	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
operation removal uterus and 2 ovaries	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
operation tubal ligation	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
opiate use	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
oral laxative drops liquid type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
oral laxative drops liquid type other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
oral laxative medication indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
oral laxative tablet capsule granulate type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
oral steroid meds	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
organ type text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
orthopedic surgeon follow-up care indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
orthosis ankle foot orthosis type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
orthosis knee ankle foot orthosis ischial weight bearing indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
orthosis other type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
orthosis stander type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
orthosis type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
orthosis use indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
os-nontraditional health practitioner for health care #1	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
os-nontraditional health practitioner for health care #4	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
os-nontraditional health practitioner go most often and no one in particular go most often #1	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
os-nontraditional remedy or therapy #1	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
os-nutritional or herbal supplements have regularly taken over the past month for menopausal symptoms #1	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
os-of those places you selected to go when you are sick or need advice about health, which place do you go most often #2	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
os-reason for stopping take female hormones #1	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
os-treatment/therapy for high blood pressure #1	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
os-type of treatment/therapy currently using for cancer #1	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
os-type of treatment/therapy currently using for cancer #2	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
os-type of treatment/therapy currently using for cancer #3	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
os-type of treatment/therapy currently using for cancer #4	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
os-vitamin, mineral, or herbal supplements you take regularly #1	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
os-vitamin, mineral, or herbal supplements you take regularly #2	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
os-vitamin, mineral, or herbal supplements you take regularly #4	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
os-vitamin, mineral, or herbal supplements you take regularly #5	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
osmotic therapy type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
osteoporosis medication	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
osteoporosis medication 2 - coded	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
osteoporosis medication 3 - coded	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
oth non-traditional therapy freq (12 mo)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
other dr. reported eye vision tx phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
other drugs or medications occurring with insomnia [phenx]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
other eye vision problem tx date phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
other eye vision problem tx phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
other female hormones name and dosage	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
other glaucoma drops phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
other hormonal meds	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
other immunosuppressant	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
other myopia treatment phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
other non-insulin, non-glp-1 receptor agonist injection medication	✓ NACC_csv	Treatment	Draft	07 May 16:15	Detail Edit
other physician follow-up care indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
other place usual healthcare place	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
other private medical	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
other professional seen for healthcare	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
other reason for other female hormones	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
other reason for stop other female hormones	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
other specify (os)-healthcare professional to see for health care #1	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
other specify (os)-healthcare professional to see for health care #3	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
other specify (os)-healthcare professional to see for health care #4	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
other specify (os)-healthcare professional to see for health care #5	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
other specify (os)-nontraditional health practitioner for health care #1	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
other specify (os)-nontraditional health practitioner for health care #3	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
other specify (os)-nontraditional health practitioner go most often and no one in particular go most often #1	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
other specify (os)-nontraditional remedy or therapy #1	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
other specify (os)-nutritional or herbal supplements have regularly taken over the past month for menopausal symptoms #1	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
other specify (os)-reason for stopping take female hormones #1	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
other specify (os)-vitamin, mineral, or herbal supplements you take regularly #1	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
other steroid meds	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
other strabismus treatment phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
other supplements for menopausal symptoms	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
other surgery: specify	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
other treament for undescended testicle [phenx]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
other treatment eye problem phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
other treatments date	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
other treatments reason type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
other treatments result type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
outpatient therapy setting type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ovaries removed at same time	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
ovary removed reason for other female hormones	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
over the counter (otc): does r take calcium supplement?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
over the counter (otc): does r take multivitamin supplement?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
over the counter (otc): frequency unit of time	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
over the counter (otc): multum drug id	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
over the counter (otc): number of non-prescription medications	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
over the counter (otc): taken for how long	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
over the counter (otc): taken for how long unit of time	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
over the counter medicine other name	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
over the counter medicine type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
over the counter or prescription allergy	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
over the counter supplement current take indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
over the counter supplement type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
overnight hospital stay required for amputation a?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
overnight hospital stay required for head injury c?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
overnight hospital stay required for joint injury b?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
overnight hospital stay required for joint injury c?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
overnight hospital stay required for motor vehicle accident c?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
overnight hospital stay required for motor vehicle accident d?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
oxygen inhaled	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
oxygen support	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
oxygen support category	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
oxygen support weaning	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
pain current treatment frequency text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
pain current treatment patient global impression change text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
pain current treatment side effect adverse event text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
pain current treatment text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
pain past treatment oral topical medication other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
pain past treatment other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
pain past treatment passive stimulaiton therapy other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
pain past treatment passive stimulation therapy type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
pain past treatment physiotherapy other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
pain past treatment physiotherapy type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
pain past treatment procedural intervention other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
pain past treatment procedural intervention type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
pain past treatment relaxation psychotherapy other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
pain past treatment relaxation psychotherapy type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
pain past treatment surgical intervention other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
pain relievers for menopausal symptoms	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
pain-relieving medication cts	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
parkinson's disease medication class category	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
parkinson's disease medication exposure duration	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
parkinson's disease medication maximum dose	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
parkinson's disease medication side effect text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
parkinson's impact scale (pims) - parkinson's disease medication indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
past surgery type indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
patient paralytics utilization indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
pcsk9 inhibitor past three month indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
pharmacological therapy indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
pharmacological therapy text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
pharmacotherapy brand	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
pharmacotherapy category: other	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
pharmacotherapy frequency	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
pharmacotherapy subcategory	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
pharmacotherapy type: other	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
phone questionnaire (question a35) other specify - treatment/therapy for high blood pressure number	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
physcial therapy minute duration	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
physical activity increase intervention other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
physical activity increase intervention type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
physical activity increase recommendation indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
physical rest after concussion duration	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
physical therapy adaptive equipment orthotic session type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
physical therapy assistive technical device type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
physical therapy device type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
physical therapy focus area type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
physical therapy intervention type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
physical therapy orthoses type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
physical therapy position type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
physical/occupation therapy 1 - therapist	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
physical/occupational therapy frequency (12 months)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
physician diagnosed blood transfusion before	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
physicians assistant/nurse practitioner seen for healthcare	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
planned interv +or serv visit freq	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
plants for menopausal symptoms	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
pneumonia episode treat antibiotic past year number	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
post-menopausal surgery date	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
postoperative complication type other	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
potency enhancing drug current former use age start value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
potency enhancing drug current former use duration	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
potency enhancing drug current former use type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
potency enhancing drug current former use type text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
potency enhancing drug former use age end value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
prednisone	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
premarin pill cts	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
prescribed medications unable to transcribe:	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
prescription medication quantity value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
prescription medications number unable to transcribe	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
prescription medicine for anxiety/depression ever (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
prescription medicine for arthritis ever (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
prescription medicine for birth control ever (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
prescription medicine for cholesterol ever (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
prescription medicine for diabetes ever (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
prescription medicine for headaches ever (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
prescription medicine for heart condition ever (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
prescription medicine for hypertension	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
prescription medicine for hypertension ever (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
prescription medicine for lung problems ever (30 days)	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
prescription medicine for ulcer ever (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
prescription medicine high cholesterol	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
pressure ulcer surgical treatment indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
prevent heart disease reason for other female hormones	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
prevent osteoporosis reason for other female hormones	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
preventive care status	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
previous surgeries	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
primary care physician follow-up care indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
primary drug target - amyloid beta	✓ NACC_csv	Treatment	Draft	07 May 16:15	Detail Edit
primary drug target - inflammation	✓ NACC_csv	Treatment	Draft	07 May 16:15	Detail Edit
primary drug target - other target(s)	✓ NACC_csv	Treatment	Draft	07 May 16:15	Detail Edit
primary drug target - other target(s), specify	✓ NACC_csv	Treatment	Draft	07 May 16:15	Detail Edit
primary drug target - synaptic plasticity/neuroprotection	✓ NACC_csv	Treatment	Draft	07 May 16:15	Detail Edit
primary drug target - tau	✓ NACC_csv	Treatment	Draft	07 May 16:15	Detail Edit
primary dx procedure phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
prior to study medication stopped duration	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
procedural bleeding risk	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
procedural dilatation/anticoagulation	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
procedure category	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
procedure date and time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
procedure type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
prompt for tagamet:	✓ ACTIVE	Treatment	Draft	07 May 16:15	Detail Edit
provider recommended stop other female hormones	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
psoriasis treatment effectiveness phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
psoriasis treatment phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
pt/ot sequence phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
pt/ot type phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
pulmonary function test bronchodilator indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
quasi med: frequency unit	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
quasi med: multum drug id	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
quasi medication: why taken midlife in the united states (midus) code	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
quit smoking products plco	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
r reports medication taken in variable dosage	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
r takes two prescription medications with same generic name	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - at what age did the second hormone drug spell for menopause or aging symptoms begin?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - before you started taking hormones for menopause or aging symptoms, had you already stopped having menstrual periods?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - have you ever gone to anyone for help about drinking?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - have you ever had surgery to remove your uterus and/or ovaries?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - have you ever stopped taking hormones for menopause or aging symptoms?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - how important to you was stopping hormones for menopause or aging symptoms because hormones didn't help you feel any better?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - how important to you was stopping hormones for menopause or aging symptoms because of the reason other than feeling better, hormones not helping you feel better, not liking having periods again, not feeling like taking hormones anymore, having difficulty remembering to take the hormones, concern about possible side effects, concern about possible long term effects, your doctor advising you to stop, or having side effects?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - how important to you was stopping hormones for menopause or aging symptoms because you didn't feel like taking it anymore?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - how important to you was stopping hormones for menopause or aging symptoms because you didn't like having periods again?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - how important to you was taking hormones for menopause or aging symptoms because you had an early menopause?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - how important to you was taking hormones for menopause or aging symptoms because you had your ovaries removed?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - how important to you was taking hormones for menopause or aging symptoms because you were having difficulties with sexual intercourse?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - how important to you was taking hormones for menopause or aging symptoms because your doctor recommended it?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - how important to you was taking hormones for menopause or aging symptoms for the reason other than to relieve menopausal symptoms such as hot flushes and night sweats, to prevent osteoporosis or brittle bones, to prevent heart disease, because you had an early menopause, because you had your ovaries removed, to regulate monthly periods, because you were having difficulties with sexual intercourse, to keep you youthful, or because your doctor recommended it?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - how important to you was taking hormones for menopause or aging symptoms to keep you youthful?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - how important to you was taking hormones for menopause or aging symptoms to prevent heart disease?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - how important to you was taking hormones for menopause or aging symptoms to prevent osteoporosis or brittle bones?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - how important to you was taking hormones for menopause or aging symptoms to regulate monthly periods?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - how important to you was taking hormones for menopause or aging symptoms to relieve menopausal symptoms, such as hot flushes and night sweats?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - how important was avoiding future pregnancy for your surgery to have your uterus and/or ovaries removed?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - how important was cancer/malignant tumors for your surgery to have your uterus and/or ovaries removed?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - how important was endometriosis for your surgery to have your uterus and/or ovaries removed?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - how important was heavy hemorrhaging or bleeding for your surgery to have your uterus and/or ovaries removed?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - how important was preventing future cancer for your surgery to have your uterus and/or ovaries removed?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - how important was the reason other than heavy hemorrhaging or bleeding, fibroids/benign tumors, endometriosis, cancer/malignant tumors, preventing future cancer, or avoiding future pregnancy for your surgery to have your uterus and/or ovaries removed?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - how important were fibroids/benign tumors for your surgery to have your uterus and/or ovaries removed?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - how old were you when you had surgery to remove your uterus and/or ovaries?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - in the last 12 months, have you had a mammogram?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - is there a second hormone drug spell for menopause or aging symptoms?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - other than estrogen or estrogen and progesterone, at what age did you start this additional hormone drug for menopausal or aging symptoms?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - other than estrogen or estrogen and progesterone, at what age did you stop taking this additional hormone drug for menopausal or aging symptoms?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - other than estrogen or estrogen and progesterone, do or did you take an additional kind of hormone drug for menopausal or aging symptoms?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - other than estrogen or estrogen and progesterone, why did you stop taking this additional hormone drug for menopausal or aging symptoms?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - other than heavy hemorrhaging or bleeding, fibroids/benign tumors, endometriosis, cancer/malignant tumors, preventing future cancer, or avoiding future pregnancy, why did you have your surgery to have your uterus and/or ovaries removed?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - other than to relieve menopausal symptoms such as hot flushes and night sweats, to prevent osteoporosis or brittle bones, to prevent heart disease, because you had an early menopause, because you had your ovaries removed, to regulate monthly periods, because you were having difficulties with sexual intercourse, to keep you youthful, or because your doctor recommended it, why did you take hormones for menopause or aging symptoms?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - other than your doctor, husband or partner, or yourself, who else had an opinion about your surgery to have your uterus and/or ovaries removed?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - what opinion did the person other than your doctor, husband or partner, or yourself have about your surgery to have your uterus and/or ovaries removed?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - what opinion did you have about your surgery to have your uterus and/or ovaries removed?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - what opinion did your doctor have about your surgery to have your uterus and/or ovaries removed?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - what opinion did your husband or partner have about your surgery to have your uterus and/or ovaries removed?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - what side effect did you experience from the hormones for menopause or aging symptoms that caused you to stop the treatment?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r04 - what type of surgery did you have to remove your uterus and/or ovaries?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - are you currently taking testosterone for menopausal or aging symptoms?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - are you enrolled in the new medicare prescription drug benefit?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - are you signed up with an hmo, a health maintenance organization, through medicare?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - are you using any pill or laxatives to lose or maintain weight?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - at what age did you have surgery to remove your uterus?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - at what age did you start taking testosterone for menopausal or aging symptoms?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - at what age did you start taking this other hormone, excluding estrogen, estrogen and progesterone, or testosterone, for menopausal or aging symptoms?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - at what age did you stop taking testosterone for menopausal or aging symptoms?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - at what age did you stop taking this other hormone, excluding estrogen, estrogen and progesterone, or testosterone, for menopausal or aging symptoms?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - century month graduate enrolled in his/her current medicare prescription drug plan	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - did graduate already have a good prescription drug coverage under another plan? was this the main reason, an important reason, or not a reason for not enrolling in a medicare prescription drug plan?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - did graduate change his/her medicare prescription drug coverage between november 15th and december 31st in r05?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - did graduate change his/her medicare prescription drug plan because new coverage offers better coverage for drugs graduate has taken for over a year?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - did graduate change his/her medicare prescription drug plan because of some reason? this excludes the old plan changed prices/coverage, new coverage has lower premiums, drug needs changed, and new coverage better for drugs taken over a year	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - did graduate change his/her medicare prescription drug plan because prescription drug needs changed and the new coverage fits needs better?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - did graduate change his/her medicare prescription drug plan because the new coverage costs less money in terms of total monthly premiums?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - did graduate change his/her medicare prescription drug plan because the old plan changed its prices or coverage and was no longer best for the graduate?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - did graduate not take enough prescriptions to need a medicare drug plan? was this the main reason, an important reason, or not a reason for not enrolling in a medicare prescription drug plan?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - did graduate or the person at least partially responsible for graduate's decision about enrolling in the medicare prescription drug benefit and which plan to choose seek advice from physician/other health care provider?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - did graduate provide the name of his/her medicare prescription drug plan or medicare advantage/hmo?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - did graduate provide the name of the medicare prescription drug plan or medicare advantage/hmo he/she had before changing coverage between november 15th and december 31st in r05?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - did graduate respondent have any health care utilization, including regular prescriptions, in the past 12 months?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - did the doctor or medical staff who cared for your deceased spouse speak to you or your spouse about making sure the care was consistent with your spouse's wishes or plans about the types of medical treatment he/she did or did not want while dying?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - did you first enroll in your military or veterans provided health insurance plan in the past 12 months?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - did you first enroll in your third privately purchased health insurance plan in the past 12 months?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - does the child with a developmental disability or long-term, serious mental illness go to a department of vocational rehabilitation, day treatment or clubhouse program?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - does your child need occupational therapy?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - does your child need psychological or psychiatric services?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - does your child receive crisis intervention services?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - does your child receive occupational therapy?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - does your child receive physical therapy?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - does your child receive psychological or psychiatric services?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - does your child receive respite services?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - does your child receive speech therapy?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - during that last week of your spouse's life, was there any medical procedure or treatment that happened to your spouse that was not consistent with his/her previously stated wishes or plans about the types of medical treatment he/she did or did not want while dying?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - during the last week of your deceased parent's life, was there any medical procedure or treatment that happened to your parent that was not consistent with his/her previously stated wishes or plans about the types of medical treatment she/he did or did not want while dying?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - during the past six months, has the child with a developmental disability or long-term, serious mental illness received services from a mental health community support program?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - has the child with a developmental disability or long-term, serious mental illness ever been admitted for an overnight stay in a hospital for mental health problems?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - have you ever taken estrogen alone for menopausal or aging symptoms?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - have you ever taken estrogen and progesterone for menopausal or aging symptoms?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - have you ever taken some hormone, other than estrogen, estrogen and progesterone, or testosterone for menopausal or aging symptoms?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - have you ever taken testosterone for menopausal or aging symptoms?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - have you gone to anyone for help about drinking, that is, about your drinking or anyone else's?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - how important was some other reason for taking hormones for menopausal or aging symptoms? other reason excluding to relieve menopausal symptoms, mood swings, depression or anxiety, to prevent heart disease, because you had early menopause, because you had your ovaries removed, to regulate monthly periods, because you were having difficulties with sexual intercourse, to keep you youthful, or your doctor recommended it	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - how important was the following reason for stopping hormones for menopausal or aging symptoms: hormones didn't help you feel any better?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - how important was the following reason for stopping hormones for menopausal or aging symptoms: you didn't feel like taking it anymore?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - how important was the following reason for stopping hormones for menopausal or aging symptoms: you didn't like having periods again?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - how important was the following reason for stopping hormones for menopausal or aging symptoms: you had difficulty remembering to take it?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - how important was the following reason for stopping hormones for menopausal or aging symptoms: you were having side effects?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - how important was the following reason for stopping hormones for menopausal or aging symptoms: you were influenced by increased news stories about hormone replacement therapy?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - how important was the following reason for stopping hormones for menopausal or aging symptoms: your doctor advised you to stop?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - how important was the following reason for taking hormones for menopausal or aging symptoms: because you had early menopause?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - how important was the following reason for taking hormones for menopausal or aging symptoms: because you were having difficulties with sexual intercourse?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - how important was the following reason for taking hormones for menopausal or aging symptoms: to keep you youthful?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - how important was the following reason for taking hormones for menopausal or aging symptoms: to relieve mood swings, depression or anxiety?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - how important was the following reason for taking hormones for menopausal or aging symptoms: your doctor recommended it?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - how many years have you been seeing your current health professional for your health care?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - if you asked for help was it for your drinking or somebody else's?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - in past 12 months, have you visited a mental health professional about a personal problem or a problem with alcohol or drugs?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - in the last 12 months, have you had a flu shot?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - in the past 12 months, have you had outpatient surgery, not including dental care?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - in the past 12 months, how many different times have you seen a dentist or oral surgeon in an office, clinic or health center?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - in your lifetime, have you tried to reduce or stop drinking alcohol but failed?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - pattern variable indicating which child/ren, if any, with whom the respondent discussed their plans and preferences with about the types of medical treatment they want if they become seriously ill in the future	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - plan number for medicare hmo plan	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - plan number for plan other than first, second, or third employer plan, first, second, or third privately purchased plan, medicare hmo plan, or medicaid hmo plan	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - please specify which joint was replaced	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - since you stopped taking hormones, have you again started taking hormones for menopausal or aging symptoms?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - to what extent do you agree that if you had many treatment options, you worry about whether your doctor cares enough to discuss each one with you for as long as you want?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - to what extent do you agree that your doctor has always let you make the final decision about your treatment when you've wanted to?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - to what extent do you agree that your doctor has not involved you in discussing your treatment options as much as you would like?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - to what extent do you agree that your doctor is the kind of person who will let you make the final decision about your treatment even if he/she disagrees?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - to what extent do you agree that your doctor is totally honest in telling you about all treatment options available for your condition?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - under the health insurance plan you were covered by before becoming uninsured, did you pay a certain percentage of the cost, a fixed dollar amount, or nothing at all for prescriptions?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - under the health insurance plan you were covered by before becoming uninsured, for each prescription, what dollar amount did you usually pay?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - under the health insurance plan you were covered by before becoming uninsured, for each prescription, what percentage did you usually pay?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - under your first employer health insurance plan, how much do you usually pay for each brand-name prescription?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - under your first employer health insurance plan, how much do you usually pay for each generic prescription?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - under your first privately purchased health insurance plan, do you pay a certain percentage of the cost, a fixed dollar amount, or nothing at all for prescriptions?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - under your first privately purchased health insurance plan, how much do you usually pay for each generic prescription?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - under your medicare hmo plan, are you responsible for any of the costs for either a visit to a doctor or to get a prescription filled?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - under your medicare hmo plan, do you pay a certain percentage of the cost, a fixed dollar amount, or nothing at all for prescriptions?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - under your medicare hmo plan, for each prescription, what percentage do you usually pay?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - under your medicare hmo plan, how much do you usually pay for each generic prescription?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - under your medicare supplemental health insurance plan, for each prescription, what percentage do you usually pay?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - under your medicare supplemental health insurance plan, how much do you usually pay for each generic prescription?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - under your previous health insurance plan, for each prescription, what percentage did you usually pay?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - under your second employer health insurance plan, do you pay a certain percentage of the cost, a fixed dollar amount, or nothing at all for prescriptions?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - under your second privately purchased health insurance plan, are you responsible for any of the costs for either a visit to a doctor or to get a prescription filled?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - under your third employer health insurance plan, are you responsible for any of the costs for either a visit to a doctor or to get a prescription filled?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - under your third employer health insurance plan, do you need to get a referral in order to see a specialist, that is, approval or permission from your doctor or health plan?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - under your third employer health insurance plan, for each prescription, what percentage do you usually pay?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - was there another health professional you saw regularly before you began seeing you current usual health professional?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - what is the specialty of your usual doctor?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - what is the specialty of your usual medical provider?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - what kind of medicare prescription drug coverage did graduate have before changing coverage between november 15th and december 31st in r05?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - what kind of new medicare plan is graduate enrolled in?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - when you stopped taking hormones, did you experience any menopausal or aging symptoms?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - where does the child with a developmental disability or long-term, serious mental illness usually go for mental health care?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - who does your military or veterans provided health insurance plan cover?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - why did you change the health professional you regularly went to?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r05 - will your second privately purchased health insurance plan pay for any of the costs of un-referred visits to specialists or other doctors not associated with the plan?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - are you currently enrolled in a medicare part d prescription drug plan?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - are you using methods other than eating fewer calories or less fat, physical activities, exercise, pills or laxatives to lose or maintain your weight?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - are you using physical activities or exercise to lose or maintain your weight?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - century-month respondent began taking 2nd medication	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - code for the 16th medication	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - code for the 20th medication	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - code for the 25th medication	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - code for the 26th medication	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - does insurance help pay for the hired person who most often helps respondent with selected basic activities of daily living (badls)?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - does insurance help pay for the hired person who most often helps respondent with selected instrumental activities of daily living (iadls)?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - does respondent currently receive prescription drug insurance through a medigap prescription drug benefit plan?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - does respondent currently receive prescription drug insurance through medicare advantage?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - does respondent currently receive prescription drug insurance through some other state prescription drug program?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - does respondent currently receive prescription drug insurance through wisconsin seniorcare?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - does respondent currently receive some other form of private health insurance coverage that works with, supplements, or replaces medicare?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - does respondent currently receive some other type of private prescription drug insurance?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - does respondent manage their diabetes by checking for sores or irritation on their feet?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - does respondent manage their diabetes by exercising regularly?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - does respondent manage their diabetes by measuring their blood pressure at home?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - does respondent manage their diabetes by taking aspirin regularly?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - does respondent manage their diabetes by testing their blood sugar at home?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - does respondent's spouse currently receive prescription drug insurance through a medigap prescription drug benefit plan?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - does respondent's spouse currently receive prescription drug insurance through medicare advantage?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - does respondent's spouse currently receive prescription drug insurance through some other state prescription drug program?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - does respondent's spouse currently receive prescription drug insurance through wisconsin seniorcare?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - does respondent's spouse currently receive some other type of private prescription drug insurance?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - does the selected non-normative child go to a department of vocational rehabilitation, day treatment or clubhouse program?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - does your child need physical therapy?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - does your child need speech therapy?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - during the past six months, has the selected non-normative child received services from a mental health community support program?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - extent to which respondent is bothered by side effects of cancer treatment(s) they have received in the past month	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - first type of treatment respondent mentioned ever receiving for their cancer	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - from what program did you receive disability benefits?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - has respondent ever participated in a diabetes self-management course or class or received special training on how they can manage their diabetes?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - has respondent needed but not gotten mental health treatment or counseling in the past 12 months?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - has respondent received treatment(s) for their cancer in the past month?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - has respondent seen or talked to a mental health professional in the past 12 months?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - has respondent's doctor or other health care professional talked to them about a treatment plan for managing diabetes?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - have you ever had cpap/bipap as a treatment for your sleep apnea?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - have you ever had surgery as a treatment for your sleep apnea?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - have you ever used a dental device as a treatment for your sleep apnea?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - have you ever used something other than weight loss, cpap/bipap, surgery, or a dental device as a treatment for your sleep apnea?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - have you ever used weight loss as a treatment for your sleep apnea?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how confident are you that you have made the right decision about your current prescription drug coverage?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how effective is eighth medication?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how effective is eleventh medication?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how effective is fifteenth medication?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how effective is fifth medication?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how effective is first medication?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how effective is fourteenth medication?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how effective is fourth medication?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how effective is ninth medication?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how effective is second medication?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how effective is seventeenth medication?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how effective is seventh medication?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how effective is sixteenth medication?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how effective is sixth medication?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how effective is tenth medication?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how effective is third medication?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how effective is thirteenth medication?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how effective is twelfth medication?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how many times did you take your 10th medication yesterday?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how many times did you take your 11th medication yesterday?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how many times did you take your 15th medication yesterday?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how many times did you take your 16th medication yesterday?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how many times did you take your 17th medication yesterday?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how many times did you take your 19th medication yesterday?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how many times did you take your 1st medication yesterday?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how many times did you take your 20th medication yesterday?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how many times did you take your 21st medication yesterday?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how many times did you take your 22nd medication yesterday?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how many times did you take your 23rd medication yesterday?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how many times did you take your 24th medication yesterday?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how many times did you take your 25th medication yesterday?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how many times did you take your 26th medication yesterday?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how many times did you take your 2nd medication yesterday?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how many times did you take your 6th medication yesterday?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how many times did you take your 7th medication yesterday?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how many times did you take your 9th medication yesterday?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - how satisfied are you with the range of drugs covered under your current medicare part d prescription drug plan?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - if you had a serious illness today with very low chances of survival and had no physical pain, but were unable to speak, walk, or recognize others, would you want to continue all medical treatments or stop all life-prolonging treatments?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - in the next 12 months, how likely is it that you will switch to a new medicare part d prescription drug plan?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - in the past 12 months, has there been any one doctor who keeps in touch with your other doctors and healthcare providers?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - in the past 12 months, has there been any one doctor who knows all of your prescription medicines?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - in the past 12 months, has there been any one doctor who knows the results of all your tests and treatments?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - in the past 12 months, have you gone to a hospital emergency room for medical treatment for yourself?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - in the past 12 months, how often has someone else used your prescription medications?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - in the past 12 months, how often have the doctors at your usual place of care appeared to agree on treatments for your health condition(s)?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - in the past 12 months, how often have you been careless about using your prescription medications?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - in the past 12 months, how often have you forgotten to take your prescription medications?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - in the past 12 months, how often have you gotten a refill when you had more than a few days of the prescription medication left?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - in the past 12 months, how often have you stopped using your prescription medications because you felt better?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - in the past 12 months, how often have you taken an extra dose of your prescription medication without talking to your doctor first because you thought it might improve your condition?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - in the past 12 months, how often have you taken less medication than your doctor prescribed because you felt better?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - is your spouse currently enrolled in a medicare part d prescription drug plan?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - medical specialty of respondent's usual provider of health care	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - month in which respondent underwent their most recent heart surgery	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - number of heart surgeries respondent has had	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - number of prescription medications son/daughter is currently taking	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - numeric component for how often respondent manages diabetes by testing their blood sugar	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - respondent's age at the time of their most recent heart surgery	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - respondent's age at the time of their most recent surgery that required anesthesia	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - season in which respondent underwent their most recent heart surgery	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - season in which respondent underwent their most recent surgery that required anesthesia	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - side effect of cancer treatment(s) received in the past month that bothers respondent the most	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - summary of how respondent responded when asked to specify the kind of anesthesia-requiring procedure they most recently underwent	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - time units: how often does the label on your 25th medication say you should take it?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - time units: how often does the label on your 2nd medication say you should take it?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - to what extent do you agree that it is very important to you that doctors at your usual place of care agree about treatments for your health condition(s)?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - to what extent do you agree that when there is more than one medication to treat a problem, you prefer that your doctor has you decide which one you should use?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - to what extent do you agree that when there is more than one medication to treat a problem, your doctor only needs to discuss the one he/she thinks is best?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - to what extent do you agree that you know the different medical treatment options available for your health condition(s)?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - to what extent do you agree that you know what each of your prescribed medications do?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - units corresponding to numeric component for how often respondent manages diabetes by checking for sores or irritation on their feet	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - was respondent's depression caused by medication?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - what is the dosage on the label of the 16th medication you take?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - what is the dosage on the label of the 2nd medication you take?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - where does the selected non-normative child usually go for mental health care?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - which of the three programs - a department of vocational rehabilitation, day treatment program, or clubhouse program - does the selected non-normative child attend?	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r06 - year respondent first had surgery on their heart	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r07 - month received 1st shot	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
r07 - year received 1st shot	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
reason - insurance company refused	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
reason began taking hormones: endometriosis	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
reason began taking hormones: heart disease	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
reason began taking hormones: memory	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
reason began taking hormones: other	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
reason began taking hormones: ovaries	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
reason for current medication: treatment of chronic conditions	✓ NACC_pdf	Treatment	Draft	07 May 16:15	Detail Edit
reason for current medication: treatment of mental health disorders or behavior problems	✓ NACC_pdf	Treatment	Draft	07 May 16:15	Detail Edit
reason for current medication: treatment of pain	✓ NACC_pdf	Treatment	Draft	07 May 16:15	Detail Edit
reason for discontinuing aspirin use	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
reason for stopping hormones: concern about risks	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
reason for stopping hormones: no longer had symptoms	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
reason for stopping hormones: other	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
reason for stopping hormones: try something else	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
reason prescribed	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
reason treated-don't know	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
reason treated-other appearance	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
reason treated-other reason	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
reason treated-physical disability	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
reason treated-refused	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
reason treated-your age	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
reason treated-your ethnicity/national	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
reason treated-your gender	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
reason treated-your height or weight	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
reason treated-your religion	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
reason treated-your sexual orientation	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
reason treated_don't know	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
reason treated_other reason	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
reason treated_physical disability	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
reason treated_refused	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
reason treated_your age	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
reason treated_your gender	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
reason treated_your height or weight	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
reason treated_your religion	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
reason treated_your sexual orientation	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
record date of hematopoietic stem cell infusion	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
record most recent blood level of immunosuppressant (prophylaxis)	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
recreational prescription drug abuse discontinue counsel indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
recreational prescription drug abuse discontinue intervention other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
recreational prescription drug abuse discontinue intervention type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
regulate periods reason for other female hormones	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
rehab services	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
rehabilitation physician follow-up care indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
rehabilitation services assessment/reception indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
rehabilitation services received type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
related to concomitant therapy	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
renal replacement therapy status	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
rescue intervention was attempted [ahrq]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiration intervention invasive tracheostomy tube indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory airway clearance medication category	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory airway clearance medication concentration value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory airway clearance medication daily frequency	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory device type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory high frequency chest wall oscillation system brand name	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory high frequency chest wall oscillation system session time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory high frequency chest wall oscillation system use daily frequency	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory high frequency chest wall oscillation system use other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory high frequency chest wall oscillation system vest other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory high frequency chest wall oscillation system vest type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory inspiratory positive airway pressure positive inspiratory pressure value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory intervention neonatal oxygen required indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory intervention neonatal problem other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory intervention neonatal problem type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory intervention-support device brand name	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory intrapulmonary percussive ventilation cup liquid other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory intrapulmonary percussive ventilation cup liquid type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory intrapulmonary percussive ventilation or metaneb daily detail type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory intrapulmonary percussive ventilation or metaneb other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory intrapulmonary percussive ventilation or metaneb session time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory intrapulmonary percussive ventilation or metaneb type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory lung volume recruitment inhale pressure value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory lung volume recruitment inhale time value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory lung volume recruitment method type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory lung volume recruitment session time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory manual cough assist session time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory manual cough assist use daily frequency	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory manual cough assist use other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory manual percussion session duration	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory manual percussion use daily frequency	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory manual percussion use frequency	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory mechanical in-exsufflator device use daily frequency	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory mechanical in-exsufflator exhale duration	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory mechanical in-exsufflator exhale pressure value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory mechanical in-exsufflator pause duration	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory mechanical in-exsufflator session cycle breath count	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory mechanical in-exsufflator session cycle set count	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory medication nebulized other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory medication nebulized type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory negative pressure initiation age value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory other airway clearance method name	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory other airway clearance method session time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory other airway clearance method use daily freq	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory oxygen administration method name	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory oxygen administration method other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory oxygen flow rate	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory oxygen use schedule daily hours value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory oxygen use schedule type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory positive end-expiratory pressure expiratory positive airway pressure value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory positive pressure initiation age value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory postural drainage session time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory postural drainage use daily frequency	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory pressure support value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory supplemental oxygen value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory support device other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory support device type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory support negative pressure device delivery method other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory support negative pressure device delivery method type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory support positive pressure device delivery method other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory support positive pressure device delivery method type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory support schedule daily hour value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory support schedule use time day type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory support type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory support use frequency	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory support ventilation device other model name	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory support ventilation mode negative pressure text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory support ventilation mode other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory support ventilation mode type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory tracheostomy date	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory tracheostomy tube brand style name	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory tracheostomy tube cuffed indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory tracheostomy tube length measurement	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory tracheostomy tube size measurement	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory tracheostomy tube timing type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory ventilation mode assist control type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory ventilation mode bi-level positive pressure type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory ventilation mode synchronized intermittent mandatory ventilation pressure support type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory ventilation support assist indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory ventilation support assist other type text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respiratory ventilation support assist type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
respondent - any rx medications covered by health insurance	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
respondent - mental health visits covered by health insurance	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
respondent has pacemaker	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
return to play rehabilitation stage complete date	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
rigid immobilization (e.g. plaster cast) for at least one week	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
rigid immobilization: joints immobilized	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
rigid immobilization: location	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
rigid immobilization: therapy type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
rigid immobilization: total time (days)	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
risk factor questionnaire (rfq) - age started regularly taking other ccb medication period 3 value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
risk factor questionnaire (rfq) - age stopped regularly taking ccb medication period 3 value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
risk factor questionnaire (rfq) - age year stop taking other anti-inflammatory medications value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
risk factor questionnaire (rfq) - currently taking ibuprofen based medication indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
risk factor questionnaire (rfq) - significant injury surgery anesthesia administered other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
risk factor questionnaire (rfq) - taken nicardipine cardene carden sr indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
rome iii constipation module (rcm3) - gallbladder removal indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
route	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
rx anxiety/depression ever (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
rx arthritis ever (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
rx arthritis frequency (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
rx birth control ever (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
rx cholesterol ever (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
rx cholesterol frequency (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
rx diabetes ever (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
rx diabetes frequency (30 days)	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
rx headaches ever (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
rx heart condition ever (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
rx heart condition frequency (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
rx hormone therapy ever (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
rx hormone therapy frequency (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
rx hypertension ever (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
rx hypertension frequency (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
rx lung problems ever (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
rx lung problems frequency (30 days)	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
rx pain ever (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
rx ulcer ever (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
rx ulcer frequency (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
sat am take sleep med - coded for med type	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
sat pm take med not usually taken - coded for med type	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
sat pm take meds not usually taken	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
saturday pm take medications not usually taken	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
scoliosis surgical treatment indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
score for indocin & motrin:	✓ ACTIVE	Treatment	Draft	07 May 16:15	Detail Edit
sedation status	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
sedation used indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
sedative/hypnotic use	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
seen physician about pain	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
seen physician/professional about pain	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
self-administered questionnaire (question a11) other specify - vitamin, mineral, or herbal supplements you take regularly number	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
self-administered questionnaire (question a39) other specify - nontraditional remedy or therapy number	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
serious adverse event concomitant medications text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
serious adverse event end date and time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
serious adverse event medication administration text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
serious adverse event reappearance indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
serious adverse event resolution indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
serious adverse event treatment description text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
serious averse event end treatment indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
should not have lasik	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
shunt type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
shunt valve functional assessment type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
shunt valve in place indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
shunt valve present indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
shunt valve removal date	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
shunt valve set type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
shunt valve surgical implantation date	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
shunt valve surgical site status	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
shunt valve type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
sickle cell anemia blood transfusion treatment indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
since the last uds visit, is new information available concerning any of the participant's prescribed treatments or clinical trial(s) of a treatment expected to modify adrd biomarkers?	✓ NACC_csv	Treatment	Draft	07 May 16:15	Detail Edit
since the last uds visit, is new information available concerning the participant's experience of amyloid related imaging abnormalities-edema (aria-e), amyloid related imaging abnormalities-hemorrhage (aria-h), or other major adverse events associated with treatments expected to modify adrd biomarkers?	✓ NACC_csv	Treatment	Draft	07 May 16:15	Detail Edit
since the start of the covid-19 pandemic (march 2020), have you needed to postpone any medical care?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
since we last interviewed you, have you tried to quit smoking?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
single orthosis side designator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
sirolimus	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
sirolimus (rapamycin)	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
skin condition medication name	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
skin condition medication work well indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
skin etiologies	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
skin thermoregulation pressure ulcer last surgically treat date	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
skin thermoregulation pressure ulcer surgically treat indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
sleep issue treatment indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
sleeping pills for menopausal symptoms	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
smoking cessation treatment indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
smoking cessation treatment type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
sodium level lower threshold value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
sodium level upper threshold value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
solid tumor response: non-target lesion	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
soy/flaxeed for menopausal symptoms	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
spasticity spasm treat last four week indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
special care unit admittance indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
special medical equipment or devices include a walker, wheelchair, nebulizer, feeding tubes, or oxygen equipment. in the last 6 months, did you get or try to get any special medical equipment or devices for your child?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
specialists are doctors like surgeons, heart doctors, allergy doctors, skin doctors, and other doctors who specialize in one area of health care. in the last 6 months, did you try to make any appointments for your child to see a specialist?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
specialized therapy service indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
specific treatment and/or trial	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
specific treatment and/or trial - nct identifier	✓ NACC_csv	Treatment	Draft	07 May 16:15	Detail Edit
specify	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
specify agent name	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
specify in vivo anti t-lymphocyte monoclonal antibody used to treat chronic gvhd	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
specify other agent used to treat chronic gvhd	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
specify other current health services	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
specify other immunosuppressant agent used	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
specify other type of cancer treatment	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
speech language pathology focus area assessment intervention type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
speech language pathology focus area augmentative alternative communication intervention type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
speech language pathology focus area cognitive development skill intervention type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
speech language pathology focus area education school intervention type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
speech language pathology focus area environment factor intervention type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
speech language pathology focus area home intervention type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
speech language pathology focus area language expressive produce intervention type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
speech language pathology focus area language receptive understand intervention type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
speech language pathology focus area language social pragmatic intervention type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
speech language pathology focus area leisure community intervention type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
speech language pathology focus area social participation intervention type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
speech language pathology focus area speech production intervention type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
speech language pathology focus area swallow dysphagia oral feed intervention type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
speech language pathology focus area vocation job intervention type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
spinal cord injury upper extremity hand reconstructive soft tissue surgery performed other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
spinal cord injury upper extremity hand reconstructive surgery performed anatomic site	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
spinal cord injury upper extremity hand reconstructive surgery performed indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
spinal cord injury upper extremity hand reconstructive surgery status	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
spinal deformity stabilization indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
spinal deformity stabilization text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
spinal elements close manipulation & reduction indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
spinal intervention or surgical procedure performance study facility indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
spinal intervention surgical procedure performance nonparticipating facility indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
spinal surgery indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
spinal surgery: specify	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
Sport Concussion Assessment Tool (SCAT) - Medication indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
sport-specific excercise rehabilitation stage completed date	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
spouse/partner - any rx medications covered by health insurance	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
spouse/partner - mental health visits covered by health insurance	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
stabilization and fusion segment level	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
stabilization and fusion segment number	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
start date (month)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
start date (year)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
static lower extremity stretch orthosis splint use anatomic site	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
static lower extremity stretch orthosis splint use frequency type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
static upper extremity orthosis splint frequency use laterality type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
static upper extremity orthosis splint use anatomic site	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
static upper extremity orthosis splint use anatomic site laterality type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
static upper extremity orthosis splint use frequency type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
stereotactic surgery frame other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
stereotactic surgery mini-frame type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
steroid administration date	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
steroid administration other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
steroid drug name	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
steroid nasal spray	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
steroid treatment duchenne or becker muscular dystrophy indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
steroid treatment start age value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
steroid treatment stop age value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
steroid treatment stop change reason	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
still taking hormone replacement	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
stimulant current former use duration	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
stimulant current former use type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
stimulation brain parameters amplitude range	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
stimulation brain parameters bipolar range	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
stimulation brain parameters frequency range	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
stimulation brain parameters monopolar range	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
stimulation brain parameters pulse width range	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
stimulation parameters brain hemisphere type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
stop reg use pain med past 3y why cts	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
strabismus treatment phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
stroke discharge medication category	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
stroke neurosurgical procedure non vascular other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
stroke surgical operative preventive neurosurgical treatment other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
stroke surgical operative preventive treatment indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
stroke surgical operative preventive treatment type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
stroke surgical therapeutic procedure other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
study drug actual return count	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
study drug dispensed count	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
study drug dispensed date and time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
study drug dosage form text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
study drug dose frequency	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
study drug dose unit of measure ucum code	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
study drug expected taken count	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
study drug returned date and time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
study therapy administered date and time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
study therapy session actual duration	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
study type	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
suboccipital craniectomy size left right measurement range	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
suboptimal response revision requirement indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
subscribed drug or substance illicitly used category	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
subscribed drug or substance illicitly used other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
substance abuse substance-related disorder current therapy personal medical history yes no indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
sun am take sleep med - coded for med type	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
sun pm take med not usually taken - coded for med type	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
sun pm take meds not usually taken	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
sunday pm take medications not usually taken	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
supplemental oxygen occurrence indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
supportive medical equipment indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
supportive medical equipment other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
supportive medical equipment type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgeries since last visit	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery age value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery amygdalohippocampectomy amygdala estimated percentage value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery amygdalohippocampectomy approach anatomic site	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery amygdalohippocampectomy hippocampus estimated length value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery anterior temporal lobectomy amygdala resection estimated percentage value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery anterior temporal lobectomy inferior temporal gyrus resection estimated length value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery anterior temporal lobectomy plus extended resection anatomic site	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery anterior temporal lobectomy plus largest depth of resection estimated value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery anterior temporal lobectomy plus largest lateral extent of resection estimated value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery anterior temporal lobectomy plus resected tissue estimated volume value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery complications	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery corpus callosotomy anatomic other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery corpus callosotomy anatomic site	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery corpus callosotomy resection extent other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery corpus callosotomy resection extent type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery diagnostic electrode type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery externalization use indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery extratemporal resection largest anterior-posterior extent estimated value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery extratemporal resection largest lateral extent estimated value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery hardware replacement type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery hemispherectomy other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery hemispherectomy type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery indication drug or medication side effects type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery intra-operative target verification source	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery intraoperative cortical stimulation mapping indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery intraoperative electrocorticogram type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery lead secure method other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery lead secure method type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery lesionectomy plus adjacent resection indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery lesionectomy plus extended resection anatomic site	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery lesionectomy plus largest anterior-posterior extent of resection estimated value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery lesionectomy plus largest depth of resection estimated value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery lesionectomy plus resected tissue estimated volume value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery lesionectomy resection extent other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery lesionectomy suspected lesion anatomic other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery multi-lobar resection lesion indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery multi-lobar resection lobe anatomic site	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery multi-lobar resection lobe indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery multi-lobar resection lobe percentage remove range	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery multiple subpial transection anatomic site	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery multiple subpial transection with resection indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery pathology hospital day count	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery post-operative medical complication other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery post-operative psychiatric complication text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery post-operative respiratory complication text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery post-operative return to operating room indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery post-operative return to operating room reason	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery post-operative seizure indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery post-operative target verification method other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery procedure duration	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery radiosurgery lobe location text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery radiosurgery marginal dose value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery radiosurgery treatment session count	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery radiosurgery treatment volume value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery reason indication other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery reason indication type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery scoliosis performed date	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery sequence phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery skull opening type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery stereotaxis type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgery vagus nerve stimulator implanted indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical complications category	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical complications intra-operative other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical complications post-operative mechanical malfunction other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical complications post-operative mechanical malfunction type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical history cardiac bypass stent indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical history cataract removal indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical history defibrillator indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical history procedure bony orthopedic surgery type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical history procedure neurological surgery type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical history procedure scoliosis other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical history procedure scoliosis type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical history procedure tendon release other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical history procedure tendon release type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical history procedure tympanostomy same ear count	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical history prosthetic implantation indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical history valve replacement indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical history: duration of hospitalization (days)	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
surgical history: procedure duration (hours)	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical history: renal transplant recipient	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical history: surgery date and time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical language laterality type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical or therapeutic gastrointestinal procedure other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical or therapeutic procedure other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical or therapeutic procedure performed indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical or therapeutic procedure text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical or therapeutic procedure type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical or therapeutic procedure ventilated indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical procedure anatomic site	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical procedure anatomic site other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical procedure approach type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical procedure arachnoid manuever type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical procedure arachnoid veil finding type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical procedure complication cerebrospinal fluid disorder indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical procedure complication fluid collection type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical procedure complication hematoma indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical procedure complication hematoma type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical procedure complication infection type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical procedure complication mechanic displacement indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical procedure complication mechanic displacement type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical procedure complications type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical procedure dural technique type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical procedure hardware anatomic site	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical procedure hardware anatomic site other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical procedure muscle spasm status	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical procedure syrinx performed type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical procedure tonsillar reduction type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical procedure trigger point anatomic site	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical procedure wound revision requirement indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
surgical procedure wound revision requirement six month indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
systemic corticosteroids	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
systemic neuro-degenerative disorder surgery caused description	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
systemic neuro-degenerative disorder surgery caused indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
tacrolimus	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
tacrolimus (fk 506, prograf)	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
taken acetaminophen ever (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
taken acetaminophen frequency (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
taken aspirin ever (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
taken aspirin frequency (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
taken birth control in past	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
taken fertility drugs in past	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
taken for how long unit of time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
taken for menstrual symptoms: aspirin, tylenol, advil, or other pain relievers	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
taken for menstrual symptoms: black cohosh, red clover, dong quai	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
taken for menstrual symptoms: creams/jellies for vaginal dryness	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
taken for menstrual symptoms: gingko biloba	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
taken for menstrual symptoms: other nutritional or herbal supplements	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
taken for menstrual symptoms: sleeping pills	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
taken for menstrual symptoms: soy supplements or flaxseed	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
taken ibuprofen frequency (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
taken naproxen ever (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
taken naproxen frequency (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
taken prescription medicine for diabetes	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
takes any supplements regularly	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
takes aspirin to prevent heart conditions	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
takes calcium regularly	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
takes creatine supplements	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
takes echinacea regularly	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
takes ephedra/ma huang regularly	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
takes feverfew regularly	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
takes fish oil regularly	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
takes flaxseed regularly	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
takes garlic regularly	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
takes gingko biloba regularly	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
takes glucosamine/chondroitin regularly	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
takes iron regularly	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
takes multi-vitamins regularly	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
takes none regularly	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
takes other supplement regularly	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
takes saw palmetto regularly	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
takes st john's regularly	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
takes vitamin c regularly	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
taking alternative medication?--yes/no	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
taking birth control currently	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
taking fertility drugs currently	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
taking other female hormones currently	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
taking over the counter medication?--yes/no	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
taking prescription medication?--yes/no	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
taking quasi (non-prescription) medication?--yes/no	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
taking quasi-medication? - yes/no	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
talk to doctor about chest pain	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
tbi therapy intensity level global assessment code	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
tbi therapy intensity level procedure indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
tbi therapy intensity level procedure type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
technical success	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
thalidomide	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
The name of the compound used in the trial	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapeutic brain stimulation placement method type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapeutic brain stimulation placement verification other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapeutic brain stimulation placement verification type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapeutic brain stimulation postoperative mri tesla value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapeutic brain stimulation pulse current value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapeutic brain stimulation pulse polarity type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapeutic brain stimulation pulse stimulus type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapeutic brain stimulation pulse voltage value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapeutic brain stimulation pulse width value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapeutic brain stimulation target anatomic site	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapeutic stretching type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapeutic use indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapist count	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapy consultative frequency	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapy factor influence session type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapy month frequency	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapy or rehabilitation assessment indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapy or rehabilitation frequency	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapy or rehabilitation received status	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapy or rehabilitation session duration	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapy or rehabilitation session week frequency	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapy or rehabilitation type	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
therapy participant count	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapy participant family caregiver count	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapy participant other count	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapy rehabilitation icd 10 cm code	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapy rehabilitation indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapy rehabilitation location type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapy rehabilitation ongoing indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapy rehabilitation service type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapy rehabilitation session other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapy session average duration time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapy session cotherapy type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapy session minute duration	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapy session type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapy setting type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
therapy week frequency	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
this participant received an anti-amyloid treatment. the use of an anti-amyloid treatment requires discontinuation of the study medication.	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
thoracolumbar brace indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
thoracolumbar brace text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
thrombectomy artery anatomic site	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
thrombectomy middle cerebral artery segment anatomic site	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
thrombolytic therapy indication: other	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
thrombolytic treatment goal	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
thrombolytic treatment goal other	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
thu pm take meds not usually taken	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
thymectomy date and time	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
thymectomy procedure comment text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
thymectomy technique type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
thymectomy transcervical type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
thymectomy transsternal type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
thymectomy videoscopic type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
thyroid replacement medication: specify	✓ NACC_pdf	Treatment	Draft	07 May 16:15	Detail Edit
thyroid surgery: specify	✓ NACC_pdf	Treatment	Draft	07 May 16:15	Detail Edit
times	✓ ACTIVE	Treatment	Draft	07 May 16:15	Detail Edit
times used a psychologist	✓ ACTIVE	Treatment	Draft	07 May 16:15	Detail Edit
times used a visiting nurse	✓ ACTIVE	Treatment	Draft	07 May 16:15	Detail Edit
times used an audiologist	✓ ACTIVE	Treatment	Draft	07 May 16:15	Detail Edit
times used physical therapist	✓ ACTIVE	Treatment	Draft	07 May 16:15	Detail Edit
to get treated early (if i am positive).	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
tocolytic agents required during preterm labor indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
tocolytic agents required during preterm specification text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
took any prescription medicine (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
took any rx medicine (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
took any rx medicine (30 dys)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
total amount received value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
total number of medications	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
total number of prescription medicines taking (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
total number of surgeries reported	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
total number of years participant has taken female hormone replacement pills	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
total numbers of supplements taking	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
total numbers rx medicine taking	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
total numbers rx medicine taking (30 days)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
total numbers rx medicine taking (30 dys)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
total rehabilitation session count	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
training improvement	✓ ACTIVE	Treatment	Draft	07 May 16:15	Detail Edit
transcranial magnetic stimulation coil type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
transcranial magnetic stimulation comments text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
transfusion indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
transfusion type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
treat heart with bypass or exercise	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
treated in last 12 months?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
treatment end date	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
treatment for clinical event indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
treatment for clinical event type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
treatment group assignment type other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
treatment info	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
treatment or experimental therapy text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
treatment start date	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
truncal support device type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
try else reason for stop other female hormones	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
tue pm take med not usually taken - coded for med type	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
tue pm take meds not usually taken	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
tuesday pm take medications not usually taken	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
tx child receive dr. reported date phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
tx child receive dr. reported phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
type of anticoagulant medication used	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
type of biopsy performed for suspected gvhd	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
type of blood thinning medication used	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
type of cancer treatment: bone marrow transplant	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
type of cancer treatment: chemotherapy	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
type of cancer treatment: hormone therapy	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
type of cancer treatment: immunotherapy	✓ NACC_csv	Treatment	Draft	07 May 16:15	Detail Edit
type of cancer treatment: other	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
type of cancer treatment: radiation	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
type of cancer treatment: surgical resection	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
type of chemo?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
type of medication used for stomach upset	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
type of neonatal nutrition	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
type of nonsteroidal anti-inflammatory drugs (nsaids) used several times a week	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
type of nutritional product [ahrq]	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
type of provider/service to whom patient was referred for behavioral assessment	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
type of provider/service to whom patient was referred for behavioral assessment-other, specify	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
type of provider/service to whom patient was referred for mental health assessment	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
type of provider/service to whom patient was referred for mental health assessment-other, specify	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
type of surgery a - coded	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
type of surgery b - coded	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
type of surgery c - coded	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
type of surgery d - coded	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
type of surgery e - coded	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
type of surgery f - coded	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
type of surgery g - coded	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
type of surgery h - coded	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
type of surgery i - coded	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
type of surgery j - coded	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
type of surgery k - coded	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
type of trauma or procedure	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
typical use of an oral device or implanted breathing pacemaker for sleep apnea at night over the past 12 months?	✓ NACC_csv	Treatment	Draft	07 May 16:15	Detail Edit
units	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
unruptured intracranial aneurysm management compliance indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
unruptured intracranial aneurysm management noncompliance text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
unruptured intracranial aneurysm management plan initial status	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
unruptured intracranial aneurysm observation reason	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
unruptured intracranial aneurysm treatment management score	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
unruptured intracranial aneurysm treatment reason	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
unruptured intracranial aneurysm treatment repair score	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
upper extremity orthosis type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
upper extremity surgery left implantable fes performed indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
upper extremity surgery left osteotomy fingers/thumb performed indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
upper extremity surgery left osteotomy radius performed indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
upper extremity surgery left osteotomy ulnar performed indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
upper extremity surgery left osteotomy wrist performed indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
upper extremity surgery left other performed indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
upper extremity surgery left soft tissue other performed indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
upper extremity surgery left soft tissue restoration pinch performed indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
upper extremity surgery left soft tissue tendon lengthenings performed indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
upper extremity surgery left soft tissue tendon wrist performed indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
upper extremity surgery right osteotomy humerus performed indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
upper extremity surgery right soft tissue other performed indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
upper extremity surgery right soft tissue reconstruction tendon elbow performed indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
upper-extremity orthopedic surgery: specify	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
urinary tract drug type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
urinary tract drug use indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
urinary tract drug use other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
urinary tract surgical procedure other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
used alternative medical treatment	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
used depress medications on own ever (12 months)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
used erectile dysfunction drug in past 12 months	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
used painkillers on own ever (12 months)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
used tranquilizers on own ever (12 months)	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
using other treatment high blood pressure	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
usual headache treatment phenx	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
vaccination within one month of demyelinating attack indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
vaccine received indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
vaccine type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
vaccine unusual history name	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
vaccines received indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
vaginal dryness reason for other female hormones	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
vasopressor use	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
vasopressor use date	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
vasopressor use indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ventilation mechanical any indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ventilation mechanical any total duration	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ventilation mechanical invasive indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ventilation mechanical invasive total duration	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ventilation mechanical noninvasive indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ventilation mechanical noninvasive total duration	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ventilation peak pressure value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ventilation positive end-expiratory pressure gas pressure value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ventilation pressure support gas pressure value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ventilator assistance utilization indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ventilator breath volume value	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ventilator mode status	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ventilator respiration rate	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ventilatory assistance type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ventilatory assistance type utilized during evaluation indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ventricular drain place type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
ventriculostomy placement indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
vertebral artery revascularization procedure other text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
vertebral artery revascularization procedure type	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
vessel occlude temporary surgery procedure count	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
vessel occlude temporary surgery procedure indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
vessel occlude temporary surgery procedure maximum duration	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
vessel occlude temporary surgery procedure total duration	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
vessel repair anatomic site	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
vestibular oculomotor therapy indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
vestibular oculomotor therapy text	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
vision therapy neuro optometry indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
volatile intravenous anesthesia indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
was a specific therapy used to treat chronic gvhd during this assessment period?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
was an agent(s) administered to treat the infection?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
was an intervention required to treat pulmonary hypertension?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
was another agent used to treat chronic gvhd?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
was any treatment of gvhd modified during this assessment period?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
was g-csf initated during this assessment period?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
was growth factor administered following the decline in neutrophil counts?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
was prophylaxis for gvhd given during this assessment period?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
was sedation medication consumed for use during mri scan?	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
was the child transplanted before or after symptoms?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
was the child transplanted?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
was treatment (medication) for ae required?	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
was your blood transfusion before 1993 diagnosed by a physician?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
wed am take sleep med - coded for med type	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
wed pm take meds not usually taken	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
weight loss counsel indicator	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
weight loss intervention type	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
were additional agents administered for the infection(s)	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
were any biopsies performed during this assessment period for suspected gvhd?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
what dosage was the participant assigned to?	✓ ADNI	Treatment	Draft	07 May 16:15	Detail Edit
what is the month when you were last immunized for hepatitis b?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
what is the month when you were last immunized for pneumonia?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
what is the name of the birth control pills? - coded	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
what is the name of the post-menopausal hormone/testosterone therapy? - coded	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
what is the name of the prednisone medication? - coded	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
what is the year when you were last immunized for pneumonia?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
what is the year when you were last immunized for tetanus and diphtheria?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
what rehabilitation treatments is your child receiving now?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
what type of care and treatment options have they recommended and what is your baby receiving?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
when did treatment end?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
when did you take birth control pills? - coded for age last time used	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
when did you take birth control pills? - coded for number of years used	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
when did you take birth control pills? - coded for usage history	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
when did you take prednisone medication? - coded for age first time used	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
when did you take prednisone medication? - coded for frequency of use	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
when was your colonoscopy? - month	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
when was your colonoscopy? - year	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
when was your flexible sigmoidoscopy? - month	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
when was your flexible sigmoidoscopy? - year	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
when was your mammogram? - year	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
where surgery a was performed	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
where surgery b was performed	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
where surgery c was performed	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
where surgery d was performed	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
where surgery e was performed	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
where surgery f was performed	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
where surgery g was performed	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
where surgery h was performed	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
where surgery i was performed	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
where surgery j was performed	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
where surgery k was performed	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
where was this surgery a performed?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
where was this surgery b performed?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
where was this surgery c performed?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
where was this surgery d performed?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
where was this surgery e performed?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
where was this surgery f performed?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
where was this surgery g performed?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
where was this surgery h performed?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
where was this surgery i performed?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
where was this surgery j performed?	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
which of the following is part of your baby's current management?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
which ones?	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
willing to change aspirin dose	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit
would choose bypass or medication	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
year first ovary removed	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
year had hysterectomy	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
year last immunized for hepatitis b	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
year last immunized for pneumonia	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
year of most recent adult cardiac surgery	✓ WLS	Treatment	Draft	07 May 16:15	Detail Edit
year of most recent congenital heart-defect repair	✓ NACC_pdf	Treatment	Draft	07 May 16:15	Detail Edit
year of most recent lower-extremity orthopedic surgery	✓ NACC_pdf	Treatment	Draft	07 May 16:15	Detail Edit
year of most recent oncology surgery	✓ NACC_pdf	Treatment	Draft	07 May 16:15	Detail Edit
year of most recent other surgery	✓ NACC_pdf	Treatment	Draft	07 May 16:15	Detail Edit
year of most recent spinal surgery	✓ NACC_pdf	Treatment	Draft	07 May 16:15	Detail Edit
year of most recent thyroid surgery	✓ NACC_pdf	Treatment	Draft	07 May 16:15	Detail Edit
year of most recent upper-extremity orthopedic surgery	✓ NACC_pdf	Treatment	Draft	07 May 16:15	Detail Edit
year second ovary removed	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
year start taking other female hormones	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
year stop taking other female hormones	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
year surgery a was performed	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
year surgery b was performed	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
year surgery c was performed	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
year surgery d was performed	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
year surgery e was performed	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
year surgery f was performed	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
year surgery g was performed	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
year surgery h was performed	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
year surgery i was performed	✓ MIDUS	Treatment	Draft	07 May 16:15	Detail Edit
zenapax (daclizumab)	✓ NIH CDEs	Treatment	Draft	07 May 16:15	Detail Edit

—

CDE Summary

Short Code

—

Domain

—

Data Type

—

Unit

—

Source System

—

Permissible Values

—

Definition

—

Permissible Values

Governance

Created

—

Updated

—

Submitted

—

Approved By

—

Review Comments

No comments yet.

View Full Detail